{"meta":{"query_hash":"50e8e9314365","filters":{"venue":"Cancer Biotherapy and Radiopharmaceuticals"},"cohort_total":55,"direct_labels_cover":0,"predictions_cover":55,"exported":55,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/50e8e9314365","api":"https://metacan.xera.ac/api/v1/cohort?venue=Cancer+Biotherapy+and+Radiopharmaceuticals"},"results":[{"id":"W1748514462","doi":"10.1089/cbr.2014.1736","title":"Innate and Adoptive Immune Cells Contribute to Natural Resistance to Systemic Metastasis of B16 Melanoma","year":2015,"lang":"en","type":"article","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatchewan Cancer Agency; University of Saskatchewan","funders":"Canadian Institutes of Health Research","keywords":"Metastasis; Melanoma; Immune system; Cytotoxic T cell; Cancer research; Immunology; Biology; CD8; Cancer; In vitro","score_opus":0.024686505494036358,"score_gpt":0.3128939068882811,"score_spread":0.2882074013942448,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1748514462","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99120796,0.0034364103,0.002787162,0.00014482907,0.000035690115,0.00006856695,0.00011634103,0.00010805423,0.0020950204],"genre_scores_gemma":[0.9953218,0.0008005471,0.0014112886,0.0000988423,0.00003639421,0.00005804098,0.00011057995,0.000013819692,0.0021486955],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9997975,0.000041471263,0.000018271327,0.000040568306,0.00005019134,0.00005201255],"domain_scores_gemma":[0.9998354,0.00002728868,0.000041207386,0.000034350196,0.00001704592,0.00004473484],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023145878,0.00035825165,0.00027624032,0.00020863011,0.000078150224,0.00024692898,0.00019561873,0.00029309886,0.0015697351],"category_scores_gemma":[0.00017744506,0.00011914099,0.0002457628,0.00005691958,0.00028926646,0.00022054894,0.00027161467,0.0010102214,0.0003674126],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018315179,0.00010243057,0.0009072929,0.000062259365,0.0000053000863,0.00007896034,0.000024297278,0.00008758352,0.993586,0.00015879062,0.00004985901,0.004754095],"study_design_scores_gemma":[0.0001980005,0.0050241393,0.036227435,0.000037033067,0.00008639795,0.002178287,0.00012572638,0.0025537896,0.9466779,0.0005045402,0.0063724695,0.000014175776],"about_ca_topic_score_codex":0.00013167848,"about_ca_topic_score_gemma":0.00022308707,"teacher_disagreement_score":0.0015697351,"about_ca_system_score_codex":0.00013584268,"about_ca_system_score_gemma":0.00013429114,"threshold_uncertainty_score":0.005251348},"labels":[],"label_agreement":null},{"id":"W1965592891","doi":"10.1089/10849780252824028","title":"Antitumor Immune Responses Derived from Transgenic Expression of CD40 Ligand in Myeloma Cells","year":2002,"lang":"en","type":"article","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatchewan Cancer Agency; University of Saskatchewan","funders":"Canadian Institutes of Health Research","keywords":"CD40; Immune system; Biology; CD8; CD154; Cancer research; Molecular biology; Cytotoxic T cell; Cell biology; Immunology; In vitro; Biochemistry","score_opus":0.03081410268097728,"score_gpt":0.30244668452570345,"score_spread":0.27163258184472616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965592891","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959447,0.0004979851,0.002453549,0.00006157495,0.00002780771,0.00002854169,0.00014791379,0.000076481825,0.00076143915],"genre_scores_gemma":[0.9967307,0.00031431983,0.0014067345,0.000047683563,0.0000116687015,0.000025317717,0.00029145618,0.0000141566925,0.0011580224],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997918,0.000027703278,0.000020343403,0.000042628937,0.000053959404,0.00006345844],"domain_scores_gemma":[0.99989724,0.000019215642,0.00003410486,0.000014671354,0.00000876283,0.000025898318],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015696215,0.00044729028,0.00023263559,0.00027032138,0.00009975903,0.00027341052,0.00014372781,0.0003687035,0.00084671815],"category_scores_gemma":[0.00010011191,0.00014757676,0.00026295186,0.00012792191,0.00021442538,0.0001617983,0.00022280477,0.0008578758,0.00028233055],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000376394,0.000019457202,0.00007048791,0.00001247605,0.0000018487558,0.000021798247,0.0000050169538,0.000028500692,0.99944204,0.000045544846,0.000007913451,0.00030720982],"study_design_scores_gemma":[0.00002663231,0.00035005226,0.0015008783,0.00000469183,0.0000178865,0.00019039126,0.000009811327,0.00064171996,0.99614596,0.00004148959,0.0010678521,0.0000025941333],"about_ca_topic_score_codex":0.00027528516,"about_ca_topic_score_gemma":0.00028000027,"teacher_disagreement_score":0.00084671815,"about_ca_system_score_codex":0.00028994406,"about_ca_system_score_gemma":0.00016501445,"threshold_uncertainty_score":0.002832532},"labels":[],"label_agreement":null},{"id":"W1966346234","doi":"10.1089/cbr.2005.20.401","title":"Vaccine of Engineered Tumor Cells Secreting Stromal Cell–Derived Factor-1 Induces T-Cell Dependent Antitumor Responses","year":2005,"lang":"en","type":"article","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; Saskatchewan Cancer Agency","funders":"Southern Medical University; Ohio State University","keywords":"Biology; CD8; In vivo; Transfection; CXC chemokine receptors; Cancer research; Immunology; Cell culture; Molecular biology; Chemokine; Immune system; Chemokine receptor","score_opus":0.01955147959924157,"score_gpt":0.2965968303704807,"score_spread":0.2770453507712391,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966346234","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976774,0.00025218507,0.0011345834,0.000041324714,0.000033146876,0.00006862907,0.00013524936,0.000059492155,0.0005979992],"genre_scores_gemma":[0.9974227,0.00019271697,0.001067892,0.00005039587,0.000018205445,0.00003995788,0.0003444701,0.0000097294715,0.0008539319],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997297,0.00003039428,0.00002288625,0.000047279755,0.000052508487,0.00011722381],"domain_scores_gemma":[0.9998584,0.0000314392,0.00004351936,0.000016344135,0.000012747291,0.000037502585],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019768237,0.00060996006,0.00045841973,0.00027544162,0.000077141034,0.00031092012,0.00020597028,0.00046136786,0.00092342735],"category_scores_gemma":[0.000175136,0.00017538633,0.00028088206,0.00011993319,0.00017254442,0.00018876055,0.00018233756,0.00088160444,0.00034544713],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023597258,0.0003221809,0.00026050577,0.000029780227,0.000009105343,0.000032588,0.0000123528935,0.00031222167,0.9973003,0.000065656015,0.00004692103,0.0013723016],"study_design_scores_gemma":[0.0001801647,0.0065548215,0.004802656,0.000021234855,0.000055077136,0.00032885972,0.000035525354,0.005844807,0.9800938,0.00006628218,0.0020088141,0.000008057206],"about_ca_topic_score_codex":0.00029063123,"about_ca_topic_score_gemma":0.0003710949,"teacher_disagreement_score":0.00092342735,"about_ca_system_score_codex":0.00028071983,"about_ca_system_score_gemma":0.00023379989,"threshold_uncertainty_score":0.0030891895},"labels":[],"label_agreement":null},{"id":"W1966889790","doi":"10.1089/cbr.2012.1390","title":"Can C-Arm Cone-Beam CT Detect a Micro-Embolic Effect After TheraSphere Radioembolization of Neuroendocrine and Carcinoid Liver Metastasis?","year":2013,"lang":"en","type":"article","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Cancer Institute; National Institutes of Health; Philips Research Americas; Société Française de Radiologie","keywords":"Medicine; Hounsfield scale; Microsphere; Nuclear medicine; Metastasis; Radiology; Neuroendocrine tumors; Selective internal radiation therapy; Carcinoid tumors; Cancer; Hepatocellular carcinoma; Computed tomography; Pathology; Internal medicine","score_opus":0.030354107035187258,"score_gpt":0.29202129505692687,"score_spread":0.2616671880217396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966889790","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99641365,0.0009257613,0.0013488984,0.0000730343,0.000007925345,0.000024186813,0.000038733182,0.000029295983,0.0011384946],"genre_scores_gemma":[0.99881494,0.00023954929,0.00063907047,0.000041624604,0.000012821849,0.000008398114,0.00004525596,0.000004383249,0.00019399829],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99989426,0.000025888981,0.000007819895,0.000022668737,0.00002299811,0.000026270929],"domain_scores_gemma":[0.9995598,0.00017582746,0.00008336061,0.000035319124,0.00008011071,0.000065552216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028692384,0.00025770106,0.00024511883,0.00059350615,0.000132528,0.00023607977,0.00021665703,0.0005457518,0.0013001381],"category_scores_gemma":[0.001409271,0.00021543569,0.00017532113,0.00027549572,0.00043933903,0.00034055105,0.00012891846,0.0002864414,0.0003850049],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036149486,0.00019866363,0.7249023,0.0001937707,0.000056510053,0.015283766,0.0002493457,0.00057161594,0.2119373,0.000107418404,0.00046605617,0.042418472],"study_design_scores_gemma":[0.00018561336,0.0016766731,0.9135884,0.00004020614,0.00015406183,0.03627175,0.00026348868,0.004956612,0.04093734,0.0001248677,0.0017741856,0.000026886839],"about_ca_topic_score_codex":0.0026614594,"about_ca_topic_score_gemma":0.003086358,"teacher_disagreement_score":0.0026614594,"about_ca_system_score_codex":0.00021570556,"about_ca_system_score_gemma":0.00018790847,"threshold_uncertainty_score":0.005291939},"labels":[],"label_agreement":null},{"id":"W1968993470","doi":"10.1089/cbr.2008.0553","title":"<sup>111</sup> In-Labeled Immunoconjugates (ICs) Bispecific for the Epidermal Growth Factor Receptor (EGFR) and Cyclin-Dependent Kinase Inhibitor, p27 <sup>Kip1</sup>","year":2009,"lang":"en","type":"article","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"Internalization; Epidermal growth factor receptor; Molecular biology; Chemistry; Kinase; Epidermal growth factor; Trastuzumab; Cancer research; Receptor; Biology; Biochemistry; Cancer","score_opus":0.057479573944970046,"score_gpt":0.38831058519363243,"score_spread":0.3308310112486624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968993470","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9734115,0.0020895244,0.014381472,0.00020580838,0.00005856137,0.000072279305,0.00024549023,0.00021872218,0.009316732],"genre_scores_gemma":[0.9698855,0.0015241503,0.018611591,0.00015257492,0.000024100282,0.00008816374,0.00091089925,0.00009578419,0.008707277],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998603,0.000025696365,0.00000871069,0.00003309115,0.0000398694,0.000032349508],"domain_scores_gemma":[0.9999223,0.000013689953,0.00002728738,0.0000068547197,0.000014872667,0.000014939094],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014783128,0.0005767316,0.00022455808,0.0001646057,0.0001324383,0.00029307455,0.00020679281,0.0003009992,0.0016602491],"category_scores_gemma":[0.000099366174,0.0001731681,0.00012501738,0.00018039349,0.00025255705,0.000205582,0.00020493242,0.00031392576,0.0006835017],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010619468,0.000016843269,0.00023355024,0.000068929425,0.000005593263,0.000053911415,0.000011825184,0.00016328288,0.9973187,0.00027253747,0.00013167417,0.001617004],"study_design_scores_gemma":[0.000006045593,0.00010988152,0.0005794445,0.0000028093714,0.000012062871,0.00019982831,0.0000072593275,0.00042833388,0.9957273,0.000015547059,0.0029093667,0.0000020631212],"about_ca_topic_score_codex":0.0002867275,"about_ca_topic_score_gemma":0.00034877995,"teacher_disagreement_score":0.0016602491,"about_ca_system_score_codex":0.0005068308,"about_ca_system_score_gemma":0.00019399439,"threshold_uncertainty_score":0.0055541396},"labels":[],"label_agreement":null},{"id":"W1975076291","doi":"10.1089/cbr.2008.0579","title":"Preclinical Assessment of an Anti-EpCAM Immunotoxin: Locoregional Delivery Provides a Safer Alternative to Systemic Administration","year":2009,"lang":"en","type":"article","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Toxin Mechanisms and Immunotoxins","field":"Immunology and Microbiology","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Viventia Bio (Canada)","funders":"","keywords":"Immunotoxin; Medicine; Systemic administration; SAFER; Epithelial cell adhesion molecule; Administration (probate law); Pharmacology; Cancer; Internal medicine; Immunology; Antibody; Monoclonal antibody; Computer science; Computer security","score_opus":0.039229123685385794,"score_gpt":0.39258485531572296,"score_spread":0.3533557316303372,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975076291","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917611,0.0011903413,0.004991545,0.00007623321,0.000029827288,0.00025288432,0.00019374525,0.00007789641,0.0014264539],"genre_scores_gemma":[0.9935654,0.0011440027,0.0026759761,0.000056722747,0.00001621539,0.00017665654,0.00031933805,0.00001658238,0.0020291193],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998653,0.000029454628,0.00000703068,0.000025315288,0.00003135683,0.000041551117],"domain_scores_gemma":[0.9998354,0.000027970651,0.000062700936,0.000016725087,0.000024671517,0.00003259359],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035191048,0.0004990277,0.00036291862,0.00024826583,0.00013062934,0.00031667048,0.00034180106,0.00047218532,0.0015078613],"category_scores_gemma":[0.0002012176,0.00012137244,0.00019753767,0.00016993235,0.0002979846,0.0003754615,0.00016865565,0.0007607399,0.00023254353],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010316134,0.0012991851,0.0004707774,0.000120596385,0.000023364142,0.00008477833,0.000029222592,0.0007553267,0.9854006,0.00022145073,0.00013882716,0.01042424],"study_design_scores_gemma":[0.00022099476,0.051956926,0.002512993,0.000016648493,0.00010454755,0.00029961276,0.00003109168,0.0011041795,0.9408891,0.00007754569,0.0027792223,0.000007149169],"about_ca_topic_score_codex":0.0005297357,"about_ca_topic_score_gemma":0.00065960333,"teacher_disagreement_score":0.0015078613,"about_ca_system_score_codex":0.00031911657,"about_ca_system_score_gemma":0.0003134843,"threshold_uncertainty_score":0.0050442815},"labels":[],"label_agreement":null},{"id":"W1978030368","doi":"10.1089/108497802760804745","title":"Flux Through Multicellular Layers of a Technetium-99m-Nitroimidazole for Imaging Hypoxia","year":2002,"lang":"en","type":"article","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research","funders":"National Cancer Institute; National Medical Research Council; Medical Research Council Canada","keywords":"Hypoxia (environmental); Nitroimidazole; Chemistry; Population; Metabolism; Technetium; Oxygen; Flux (metallurgy); Biochemistry; Biophysics; Radiochemistry; Biology; Medicine; Nuclear chemistry","score_opus":0.03282947349751262,"score_gpt":0.32631579221871515,"score_spread":0.2934863187212025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978030368","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97290015,0.0029641853,0.022127248,0.000121765566,0.000019211802,0.000036194822,0.0001291898,0.00015522793,0.001546861],"genre_scores_gemma":[0.97074497,0.0016789458,0.0241369,0.000039788483,0.000009186546,0.000040031005,0.00021520694,0.00005107242,0.0030839248],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999001,0.000026009948,0.0000039793435,0.000027095195,0.000024811387,0.00001801026],"domain_scores_gemma":[0.9998248,0.00008015044,0.00003354545,0.00001668728,0.000025340592,0.000019498953],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000290341,0.0002490197,0.0002504044,0.000323356,0.00018537186,0.0003709251,0.00025354553,0.00043636473,0.00059444935],"category_scores_gemma":[0.00023492494,0.00021286462,0.00013446552,0.0002405798,0.00018884157,0.0003873487,0.00021673802,0.00033974784,0.00017503083],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006896016,0.000008794465,0.00018763627,0.000024552764,0.000003112577,0.000024498268,0.000015478989,0.00011398333,0.9981687,0.000072191775,0.000018603523,0.0012934463],"study_design_scores_gemma":[0.00000996742,0.00015806225,0.0031475453,0.0000045968936,0.000016026705,0.00016931733,0.000018904795,0.0040475684,0.99102914,0.000028846938,0.0013642688,0.0000057429666],"about_ca_topic_score_codex":0.002582375,"about_ca_topic_score_gemma":0.0028984933,"teacher_disagreement_score":0.002582375,"about_ca_system_score_codex":0.0005903091,"about_ca_system_score_gemma":0.00026504576,"threshold_uncertainty_score":0.0051347017},"labels":[],"label_agreement":null},{"id":"W1989861712","doi":"10.1089/cbr.2007.368-r","title":"Review: Cancer Immunotherapy by Exosome-Based Vaccines","year":2007,"lang":"en","type":"review","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Saskatchewan Cancer Agency; University of Saskatchewan","funders":"","keywords":"Immunotherapy; Exosome; Immune system; Cancer immunotherapy; Cytotoxic T cell; Microvesicles; Cancer; Cancer research; Antigen; Immunology; CD8; Dendritic cell; Tumor antigen; Medicine; Biology; In vitro; Internal medicine; microRNA","score_opus":0.05512507250976998,"score_gpt":0.4479299156398748,"score_spread":0.3928048431301048,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989861712","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00026937094,0.9938008,0.0004475279,0.0006435865,0.0021134692,0.000024944517,0.000054548924,0.000031350963,0.0026143936],"genre_scores_gemma":[0.0006922379,0.9946108,0.00044383874,0.0005499415,0.00068459933,0.000026167974,0.00010380456,0.0000048835905,0.0028837365],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99986243,0.000020386151,0.000018732931,0.000022429107,0.000063120686,0.000012893436],"domain_scores_gemma":[0.9998242,0.00005054198,0.000027445909,0.000005173855,0.000059878468,0.00003282537],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032879732,0.0011831316,0.0014888913,0.0017024347,0.00031512367,0.0009631825,0.00085966045,0.001139369,0.0062973155],"category_scores_gemma":[0.0004889537,0.0002587277,0.00035988292,0.0021091506,0.0002707106,0.0014970924,0.0005543549,0.001303682,0.0062447735],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000112051355,0.00009581108,0.00011566847,0.012810392,0.00009075987,0.00031623672,0.000042398082,0.00041748505,0.00409533,0.0016159557,0.119732544,0.8605554],"study_design_scores_gemma":[0.00001955,0.000063601736,0.00034778484,0.0013082286,0.00004737369,0.0011214266,0.00003084938,0.000056532906,0.0005422904,0.0006530419,0.9957991,0.000010167567],"about_ca_topic_score_codex":0.0005339816,"about_ca_topic_score_gemma":0.00091430306,"teacher_disagreement_score":0.0062973155,"about_ca_system_score_codex":0.00057493907,"about_ca_system_score_gemma":0.00087336224,"threshold_uncertainty_score":0.021066606},"labels":[],"label_agreement":null},{"id":"W1993243559","doi":"10.1089/cbr.2000.15.339","title":"<i>In Vitro</i> Comparison of Sestamibi, Tetrofosmin, and Furifosmin as Agents for Functional Imaging of Multidrug Resistance in Tumors","year":2000,"lang":"en","type":"article","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"University of Toronto","keywords":"Multiple drug resistance; In vitro; Medicine; Medical physics; Pharmacology; Nuclear medicine; Drug resistance; Biology; Genetics","score_opus":0.028927514621131602,"score_gpt":0.3684227733358898,"score_spread":0.3394952587147582,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993243559","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9673136,0.009306058,0.016309667,0.00053896994,0.00012078291,0.00019123622,0.00077241805,0.00020025868,0.0052470434],"genre_scores_gemma":[0.96725535,0.005229456,0.020738825,0.0002247049,0.00010118482,0.00029583558,0.0018332615,0.00018153443,0.004139774],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99935573,0.0003664066,0.000033597473,0.0000650484,0.000069943606,0.00010922863],"domain_scores_gemma":[0.99956745,0.00019792488,0.00007123421,0.000031119445,0.00008697726,0.00004524192],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00084483484,0.000680425,0.00062489836,0.000318519,0.0002650594,0.00058413245,0.0004014064,0.0006490515,0.001028517],"category_scores_gemma":[0.0004871854,0.00041745303,0.00041678402,0.0003301165,0.00026160676,0.0004250708,0.0001749549,0.00065790035,0.00045637833],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050410995,0.00008232643,0.0001303414,0.00009799878,0.000018441633,0.000052520347,0.000052273448,0.0003188412,0.9970425,0.00011079774,0.0001146802,0.00147533],"study_design_scores_gemma":[0.000026799238,0.0009573053,0.0008668362,0.000005300536,0.000033839373,0.00015056433,0.000025775671,0.0017244819,0.99506336,0.000022216289,0.001116026,0.00000752028],"about_ca_topic_score_codex":0.0030237166,"about_ca_topic_score_gemma":0.0022637101,"teacher_disagreement_score":0.0030237166,"about_ca_system_score_codex":0.000718624,"about_ca_system_score_gemma":0.00030206778,"threshold_uncertainty_score":0.0060122013},"labels":[],"label_agreement":null},{"id":"W1993742651","doi":"10.1089/cbr.2006.21.146","title":"Intradermal Vaccination of Dendritic Cell–Derived Exosomes Is Superior to a Subcutaneous One in the Induction of Antitumor Immunity","year":2006,"lang":"en","type":"article","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatchewan Cancer Agency","funders":"Canadian Institutes of Health Research; National Institute for Health and Care Research; Saskatchewan Health Research Foundation; National Institutes of Health; University of Saskatchewan","keywords":"Vaccination; Microvesicles; Immunology; Immunity; Medicine; Dendritic cell; Immune system; Cell mediated immunity; Immunotherapy; Biology","score_opus":0.022478847394798766,"score_gpt":0.30342283462827313,"score_spread":0.28094398723347436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993742651","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909917,0.003207018,0.0032280216,0.00019727455,0.00024321483,0.000096091964,0.00014228301,0.00014119499,0.001753244],"genre_scores_gemma":[0.9940064,0.001307926,0.0026560514,0.00008547811,0.000079161764,0.000059832673,0.00023267778,0.000029847812,0.0015425612],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995307,0.0001284053,0.000046732817,0.00009794559,0.000087294415,0.00010894353],"domain_scores_gemma":[0.99956805,0.00009280531,0.0001300822,0.00006863538,0.000033939763,0.00010638538],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044522499,0.00062351726,0.0009392129,0.00041366633,0.00014884684,0.0005583219,0.00021095546,0.000674169,0.0011591392],"category_scores_gemma":[0.00051976537,0.00016011318,0.00038395554,0.00027741614,0.00036687186,0.0005277515,0.00018572572,0.0012038775,0.0004320798],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003360664,0.0018936602,0.0004908737,0.0002056331,0.000035648645,0.000060313316,0.000026115802,0.0002266825,0.97508436,0.00017819344,0.0002138568,0.018224],"study_design_scores_gemma":[0.0005339242,0.027522849,0.0037421712,0.000028409782,0.00012993315,0.00038805525,0.000044143027,0.0016059965,0.9632122,0.00011445725,0.0026639726,0.000013909348],"about_ca_topic_score_codex":0.00019038591,"about_ca_topic_score_gemma":0.00027386003,"teacher_disagreement_score":0.0011591392,"about_ca_system_score_codex":0.00024278638,"about_ca_system_score_gemma":0.00038486108,"threshold_uncertainty_score":0.0038776994},"labels":[],"label_agreement":null},{"id":"W1999142044","doi":"10.1089/cbr.2004.19.627","title":"Preclinical Investigations of Drug and Radionuclide Conjugates of Bisphosphonates for the Treatment of Metastatic Bone Cancer","year":2004,"lang":"en","type":"article","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Bone health and treatments","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Bisphosphonate; Conjugate; Medicine; Chemotherapy; In vivo; Therapeutic index; Toxicity; Pharmacology; Distribution (mathematics); Fluorouracil; Pharmacokinetics; Radiation therapy; Drug; Internal medicine; Osteoporosis; Biology","score_opus":0.08922485021045369,"score_gpt":0.44293684926101,"score_spread":0.35371199905055634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999142044","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9709991,0.010985323,0.010108826,0.00046305326,0.00022564798,0.0017910872,0.00083625194,0.0002346209,0.0043561165],"genre_scores_gemma":[0.97416466,0.009902761,0.008337721,0.00014870662,0.000092183494,0.0010716474,0.0014309742,0.000063688465,0.0047877063],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995813,0.00012893199,0.000018709632,0.00004826808,0.00011712853,0.00010570354],"domain_scores_gemma":[0.99963284,0.000085347834,0.00006334666,0.000031406034,0.00007042577,0.000116531555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009981238,0.00092227204,0.0010973812,0.0007213995,0.00034739365,0.0006297466,0.00083331094,0.0007717943,0.0022084098],"category_scores_gemma":[0.0006214867,0.00046238754,0.00052373775,0.00045533042,0.00048391594,0.0005073345,0.00022570365,0.0013374272,0.0005383108],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029735973,0.005580381,0.00056877127,0.0005429091,0.00012218408,0.00027141167,0.00012590353,0.0041398746,0.9636014,0.00097625266,0.0007776183,0.02031957],"study_design_scores_gemma":[0.0015671286,0.089960515,0.0019437517,0.00004380901,0.00022360381,0.0005443653,0.000049880433,0.004054313,0.8916216,0.00023834576,0.00972877,0.000023892573],"about_ca_topic_score_codex":0.0012703999,"about_ca_topic_score_gemma":0.002177531,"teacher_disagreement_score":0.0022084098,"about_ca_system_score_codex":0.00067039015,"about_ca_system_score_gemma":0.0008195114,"threshold_uncertainty_score":0.0073878765},"labels":[],"label_agreement":null},{"id":"W1999287766","doi":"10.1089/108497802320970217","title":"Advances in Dendritic Cell-Based Vaccine of Cancer","year":2002,"lang":"en","type":"review","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatchewan Cancer Agency; University of Saskatchewan","funders":"","keywords":"Antigen; CTL*; Dendritic cell; In vivo; Immunology; Biology; Immune system; Chemokine; Cancer research; Antigen-presenting cell; Tumor antigen; In vitro; Immunotherapy; T cell; CD8","score_opus":0.03928933383198763,"score_gpt":0.39346241476117694,"score_spread":0.3541730809291893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999287766","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0026430986,0.98364544,0.006719627,0.0010435072,0.00093425304,0.00004647448,0.00008216203,0.0000379208,0.004847498],"genre_scores_gemma":[0.014341991,0.97603476,0.0055551846,0.0007854496,0.0007474896,0.00006264925,0.00019937534,0.000011845793,0.002261331],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999742,0.00005694901,0.000032138745,0.000040246447,0.000096443415,0.00003221712],"domain_scores_gemma":[0.9998412,0.000054142645,0.000018654006,0.000008507819,0.000058518544,0.000018847684],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069241994,0.00042449313,0.0006289293,0.0008932912,0.00017323547,0.0005900422,0.00044856998,0.0007726589,0.0014507275],"category_scores_gemma":[0.00043482258,0.00022671303,0.00047489227,0.0009062017,0.00025060718,0.0009895213,0.0005144113,0.0014185687,0.0011591839],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024168547,0.00023071047,0.0004989561,0.014153976,0.00010880597,0.00041453855,0.00014260475,0.0026705926,0.07426197,0.023355396,0.01943758,0.86448324],"study_design_scores_gemma":[0.00004201521,0.0004618554,0.00067815324,0.0009887357,0.00011315658,0.00095795223,0.000041915122,0.001226135,0.025023323,0.005551853,0.96488446,0.00003051749],"about_ca_topic_score_codex":0.0004790129,"about_ca_topic_score_gemma":0.0005695587,"teacher_disagreement_score":0.0014507275,"about_ca_system_score_codex":0.0005572232,"about_ca_system_score_gemma":0.0007278447,"threshold_uncertainty_score":0.0048531294},"labels":[],"label_agreement":null},{"id":"W1999849102","doi":"10.1089/cbr.2000.15.561","title":"Accuracy of Gamma Probes in Localizing Radioactivity: In-Vitro Assessment and Clinical Implications","year":2000,"lang":"en","type":"article","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Advanced Radiotherapy Techniques","field":"Physics and Astronomy","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute","keywords":"Gamma probe; Nuclear medicine; Full width at half maximum; Gamma ray; Technetium; Gamma camera; Sentinel lymph node; Chemistry; Medicine; Physics; Optics; Cancer; Nuclear physics","score_opus":0.041071631844506795,"score_gpt":0.4550022861993674,"score_spread":0.4139306543548606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999849102","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95075655,0.015845984,0.030804867,0.0003013486,0.00008979734,0.00009132729,0.0001703157,0.00012137719,0.0018184152],"genre_scores_gemma":[0.9915558,0.0019297288,0.0059803333,0.000057521956,0.000023155972,0.000028020651,0.00014828196,0.000030342946,0.00024684748],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975188,0.0016247334,0.00016438961,0.0002253227,0.00033664887,0.00013023303],"domain_scores_gemma":[0.9853532,0.011053621,0.0014681388,0.0007704618,0.0012287716,0.00012576947],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0045585125,0.00057311304,0.00042963887,0.00040521534,0.00018313088,0.0007976369,0.0005259983,0.00062111695,0.0014887609],"category_scores_gemma":[0.009169874,0.0003488589,0.0002817199,0.00034717083,0.0009117485,0.0005643968,0.00031112353,0.00069342606,0.00044224397],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002882109,0.00032061664,0.036947656,0.00085608975,0.00017001599,0.0002775841,0.00041919106,0.0059227403,0.9109732,0.00033856955,0.00036846517,0.040523693],"study_design_scores_gemma":[0.000050516122,0.0051596514,0.046364073,0.00006460617,0.000298938,0.0019020012,0.0002621678,0.009044907,0.93411994,0.0001804121,0.0025073504,0.000045358338],"about_ca_topic_score_codex":0.0013070394,"about_ca_topic_score_gemma":0.0007550631,"teacher_disagreement_score":0.0045585125,"about_ca_system_score_codex":0.0007204816,"about_ca_system_score_gemma":0.0002918869,"threshold_uncertainty_score":0.024108052},"labels":[],"label_agreement":null},{"id":"W2000526872","doi":"10.1089/cbr.2009.0706","title":"The <i>In Vitro</i> and <i>In Vivo</i> Antitumor Activity of Adenovirus-Mediated Interleukin-24 Expression for Laryngocarcinoma","year":2010,"lang":"en","type":"article","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Cancer research; In vivo; Angiogenesis; Apoptosis; Downregulation and upregulation; In vitro; Cell growth; Cell culture; Biology; Gene","score_opus":0.020963673325935885,"score_gpt":0.34511288956079883,"score_spread":0.3241492162348629,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000526872","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99326104,0.0021266392,0.0025457528,0.00011611797,0.000053351978,0.00003711746,0.0002976455,0.00009016873,0.0014721804],"genre_scores_gemma":[0.99558747,0.001185979,0.0014419743,0.00003235665,0.000014213843,0.000055016273,0.0004566807,0.000011906186,0.0012143404],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998716,0.00002924252,0.00001781076,0.000019404735,0.000029297622,0.0000326471],"domain_scores_gemma":[0.9999269,0.000010768972,0.000026431368,0.0000116407045,0.000009674294,0.000014568083],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015649619,0.00039746097,0.00017180892,0.00019082428,0.00009562842,0.00024902206,0.00014633818,0.00015438943,0.0008811279],"category_scores_gemma":[0.000086513755,0.000100640464,0.00034970389,0.000102442566,0.000216988,0.0001634273,0.0000892509,0.0005402981,0.00019438879],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012120017,0.00006745838,0.00013734553,0.000046416462,0.000005394954,0.000022243228,0.000010295473,0.00008703436,0.99849665,0.00008160659,0.000042002506,0.00088242686],"study_design_scores_gemma":[0.000016349568,0.00050185825,0.0010356038,0.0000025907855,0.000016670172,0.00009890517,0.000009350905,0.00038759666,0.997045,0.000017219234,0.0008668979,0.0000020239886],"about_ca_topic_score_codex":0.0005946769,"about_ca_topic_score_gemma":0.0005659161,"teacher_disagreement_score":0.0008811279,"about_ca_system_score_codex":0.00027187218,"about_ca_system_score_gemma":0.00027402144,"threshold_uncertainty_score":0.002947688},"labels":[],"label_agreement":null},{"id":"W2007734777","doi":"10.1089/cbr.2000.15.15","title":"Pretargeted Radioimmunotherapy (PRIT™) for Treatment of Non-Hodgkin's Lymphoma (NHL): Initial Phase I/II Study Results","year":2000,"lang":"en","type":"article","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":137,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nexen (Canada)","funders":"","keywords":"Radioimmunotherapy; Pretargeting; Medicine; Biodistribution; Conjugate; Nuclear medicine; Rituximab; Lymphoma; Pharmacokinetics; Antibody; Internal medicine; Chemistry; Monoclonal antibody; Immunology","score_opus":0.07038171382198578,"score_gpt":0.4769027952507788,"score_spread":0.406521081428793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007734777","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98772484,0.006555201,0.0015515331,0.00023215171,0.00005562377,0.0015845866,0.00038881175,0.00013067242,0.0017766366],"genre_scores_gemma":[0.9875838,0.0042392104,0.0020686423,0.00064910005,0.00013002245,0.0016347,0.0016151577,0.00003696706,0.00204244],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.999572,0.00020013707,0.000017140872,0.000053809785,0.000055214863,0.000101774014],"domain_scores_gemma":[0.99964714,0.00008269727,0.00004638595,0.000035320085,0.000046376485,0.0001420843],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013827941,0.0008722836,0.0015162302,0.0002890702,0.00026459305,0.00065865193,0.0005443855,0.0006209269,0.0011700289],"category_scores_gemma":[0.00054375385,0.00029907012,0.0006678371,0.00023832823,0.0004735001,0.00039475318,0.00019758081,0.0015694988,0.0003967068],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19250433,0.07467586,0.016233506,0.0015232076,0.0014535548,0.00089570344,0.0011060456,0.0045957468,0.22419585,0.0004945775,0.0047230534,0.47759855],"study_design_scores_gemma":[0.047956575,0.8904532,0.02370127,0.00005405766,0.0006826393,0.0007946102,0.00007750273,0.0011809176,0.02707316,0.00011036347,0.007885852,0.000029792185],"about_ca_topic_score_codex":0.00071463047,"about_ca_topic_score_gemma":0.0014137763,"teacher_disagreement_score":0.0015162302,"about_ca_system_score_codex":0.00061043055,"about_ca_system_score_gemma":0.0007138212,"threshold_uncertainty_score":0.007313013},"labels":[],"label_agreement":null},{"id":"W2008981569","doi":"10.1089/cbr.2006.370","title":"Adenovirus-Mediated Il-24 Expression Suppresses Hepatocellular Carcinoma Growth via Induction of Cell Apoptosis and Cycling Arrest and Reduction of Angiogenesis","year":2007,"lang":"en","type":"article","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Cancer research; Angiogenesis; Apoptosis; Genetic enhancement; Downregulation and upregulation; Cell cycle checkpoint; Tumor suppressor gene; Biology; Cell growth; Cell cycle; In vivo; Immunology; Cancer; Carcinogenesis; Gene","score_opus":0.02577899400236391,"score_gpt":0.31735752925913036,"score_spread":0.29157853525676647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008981569","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99518174,0.0016450245,0.0021116743,0.00007122626,0.000030473951,0.00003141336,0.00011094358,0.00007854326,0.0007388765],"genre_scores_gemma":[0.9949216,0.00094285974,0.0021099197,0.000024332725,0.000012409866,0.000042279436,0.00024099372,0.000008526841,0.0016970416],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99991727,0.00001814108,0.000009064111,0.000012293789,0.000020831743,0.000022333155],"domain_scores_gemma":[0.9999393,0.000011340604,0.000017367274,0.000009322711,0.000008026622,0.000014578826],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013923162,0.00031619114,0.00020990551,0.00018995455,0.00009283884,0.0002015246,0.00016290128,0.0001470841,0.0007036364],"category_scores_gemma":[0.00010042314,0.00006713205,0.00021588168,0.00010120653,0.00020368278,0.00012821353,0.00009068921,0.00045474424,0.00017312715],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013071694,0.000065430344,0.00015418725,0.000034008583,0.0000033366944,0.000036340414,0.000011965788,0.00008347323,0.99728286,0.00008888086,0.000024264704,0.002084428],"study_design_scores_gemma":[0.000041560997,0.00074478355,0.0015049819,0.000003660995,0.000014105451,0.00013435105,0.000016852351,0.0009304863,0.99423933,0.00004237178,0.002324383,0.0000031052302],"about_ca_topic_score_codex":0.00035594744,"about_ca_topic_score_gemma":0.00046151763,"teacher_disagreement_score":0.0007036364,"about_ca_system_score_codex":0.00025510346,"about_ca_system_score_gemma":0.00020796062,"threshold_uncertainty_score":0.0023539066},"labels":[],"label_agreement":null},{"id":"W2010664444","doi":"10.1089/cbr.2011.1047","title":"Synergistic Tumor Suppression by Adenovirus-Mediated Inhibitor of Growth 4 and Interleukin-24 Gene Cotransfer in Hepatocarcinoma Cells","year":2011,"lang":"en","type":"article","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"Government of Jiangsu Province; National Science Foundation","keywords":"Cancer research; Angiogenesis; Fas ligand; Downregulation and upregulation; Tumor suppressor gene; Biology; Vascular endothelial growth factor; Genetic enhancement; Apoptosis; Cancer; Carcinogenesis; Programmed cell death; Gene","score_opus":0.02856794852973225,"score_gpt":0.3058836997644912,"score_spread":0.27731575123475893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010664444","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99563736,0.00095247757,0.0019996972,0.00004652021,0.000044778983,0.000040193932,0.00015314682,0.00009921207,0.0010267214],"genre_scores_gemma":[0.9949727,0.00071957574,0.0014716203,0.000018856832,0.000009536285,0.00006741135,0.00029566922,0.000010026437,0.0024346348],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99986315,0.000027098278,0.000014999224,0.00002145315,0.00003652061,0.000036831763],"domain_scores_gemma":[0.999926,0.00001170671,0.000019694775,0.000014429454,0.0000075801922,0.000020591622],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014436898,0.0004878622,0.00024896368,0.00028017143,0.00010076328,0.00017473951,0.000120991004,0.00012262464,0.0009143418],"category_scores_gemma":[0.00006226798,0.00013234021,0.00030234436,0.00016569685,0.00018779331,0.00015815684,0.00018387556,0.00042383623,0.00021515405],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020247669,0.00006144196,0.00017587452,0.000028930224,0.000005815242,0.00005100562,0.00001641229,0.00006244621,0.99859804,0.00007799757,0.000031942407,0.00068756606],"study_design_scores_gemma":[0.00004042862,0.00087357004,0.0017915053,0.000002490028,0.000026465155,0.00015869192,0.000021866541,0.0009937057,0.99453604,0.000021702896,0.0015304796,0.0000031237132],"about_ca_topic_score_codex":0.000887541,"about_ca_topic_score_gemma":0.0010944954,"teacher_disagreement_score":0.0009143418,"about_ca_system_score_codex":0.0002428322,"about_ca_system_score_gemma":0.00026588148,"threshold_uncertainty_score":0.0030587316},"labels":[],"label_agreement":null},{"id":"W2011876126","doi":"10.1089/cbr.2005.20.260","title":"Significant Tumor Regression Induced by Microencapsulation of Recombinant Tumor Cells Secreting Fusion Protein","year":2005,"lang":"en","type":"article","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; Saskatchewan Cancer Agency","funders":"","keywords":"Fusion protein; Tumor necrosis factor alpha; Antigen; Cytotoxic T cell; Antibody; Cancer research; Cytokine; Monoclonal antibody; Recombinant DNA; Molecular biology; Immunotherapy; Fusion gene; In vitro; Chemistry; Biology; Immune system; Immunology; Biochemistry; Gene","score_opus":0.035192723681609375,"score_gpt":0.36757423292700575,"score_spread":0.3323815092453964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011876126","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902006,0.0012378739,0.0072773043,0.00005552884,0.000049321112,0.000047863967,0.00010310025,0.00014709476,0.00088128255],"genre_scores_gemma":[0.99245185,0.0006533492,0.005001862,0.000020531868,0.00001237455,0.000038573697,0.00015422932,0.000025901008,0.0016413298],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999882,0.000012872102,0.000009035413,0.000027584263,0.000036107453,0.000032411106],"domain_scores_gemma":[0.99988675,0.000033224587,0.00003628761,0.000016766591,0.0000105395,0.000016548593],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011335267,0.00040124322,0.00031371933,0.00019699523,0.00008526678,0.00023185856,0.00013839363,0.00025934214,0.0005936453],"category_scores_gemma":[0.00013181505,0.00013201026,0.00023824963,0.00010108626,0.00023707177,0.00019126691,0.0001753096,0.0004938855,0.00021274491],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025955138,0.000011571161,0.000043939013,0.000010944912,0.0000025526888,0.000018525274,0.000005623222,0.00007608173,0.9991128,0.000028795797,0.000007918309,0.00065523153],"study_design_scores_gemma":[0.0000049365667,0.00013355241,0.00027439895,9.2107274e-7,0.000006541966,0.000050615086,0.0000028562702,0.00037298648,0.99875367,0.000006471129,0.00039194233,0.0000010716511],"about_ca_topic_score_codex":0.00053415366,"about_ca_topic_score_gemma":0.00059154705,"teacher_disagreement_score":0.0005936453,"about_ca_system_score_codex":0.0002653125,"about_ca_system_score_gemma":0.00016948734,"threshold_uncertainty_score":0.0019859076},"labels":[],"label_agreement":null},{"id":"W2014028676","doi":"10.1089/cbr.2007.334","title":"Antitumor Effect of Large Doses IL-2-Activated HLA Haploidentical Peripheral Blood Stem Cells on Refractory Metastatic Solid Tumor Treatment","year":2007,"lang":"en","type":"article","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Vanderbilt University Medical Center","keywords":"Medicine; Immunotherapy; Refractory (planetary science); IL-2 receptor; Oncology; Immunology; Internal medicine; Immune system; Cancer research; T cell; Biology","score_opus":0.021575879480840155,"score_gpt":0.3482337635127965,"score_spread":0.32665788403195634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014028676","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99896765,0.0004699318,0.0001500047,0.000018162695,0.0000070573305,0.000016184924,0.00002251093,0.000011305818,0.00033713705],"genre_scores_gemma":[0.9992993,0.0001866098,0.00018472425,0.000019085457,0.000009453241,0.000016572958,0.00008701964,0.000002558703,0.00019473201],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999175,0.000030688305,0.0000055709825,0.000013916059,0.0000158263,0.000016476017],"domain_scores_gemma":[0.9999143,0.000026722453,0.000017208535,0.000012654421,0.000004520605,0.000024692554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016896518,0.0002272814,0.00030593286,0.00011970697,0.00009311121,0.00018459895,0.00010775766,0.0001565496,0.0010535652],"category_scores_gemma":[0.00017338585,0.000055539273,0.00010787969,0.0000891037,0.00018616133,0.000095037525,0.00013665024,0.0003636679,0.00013083803],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009818756,0.0022574838,0.0086948145,0.00030300856,0.00011315269,0.00067727355,0.00030036268,0.0038666362,0.89329857,0.00032222367,0.00067174534,0.07967587],"study_design_scores_gemma":[0.00453035,0.13309129,0.05908376,0.00008118443,0.0003461917,0.0040784446,0.00016999443,0.006824614,0.781541,0.00029918793,0.0099322265,0.00002175858],"about_ca_topic_score_codex":0.000114800176,"about_ca_topic_score_gemma":0.00016491144,"teacher_disagreement_score":0.0010535652,"about_ca_system_score_codex":0.000115984905,"about_ca_system_score_gemma":0.0001398226,"threshold_uncertainty_score":0.0035245419},"labels":[],"label_agreement":null},{"id":"W2014641713","doi":"10.1089/cbr.2008.0461","title":"Inhibition of Pancreatic Carcinoma Growth by Adenovirus-Mediated Human Interleukin-24 Expression in Animal Model","year":2008,"lang":"en","type":"article","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Cancer research; Genetic enhancement; Angiogenesis; Vascular endothelial growth factor; Tumor suppressor gene; Biology; Carcinoma; Pancreatic cancer; Pancreatic tumor; Pancreatic disease; Pancreas; Pathology; Medicine; Carcinogenesis; Endocrinology; Gene; Cancer; VEGF receptors","score_opus":0.03924960948422688,"score_gpt":0.346714339785522,"score_spread":0.3074647303012951,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014641713","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96114045,0.005793964,0.023088012,0.00066175516,0.00031702072,0.0004944255,0.0012546749,0.00075562124,0.0064940946],"genre_scores_gemma":[0.9726059,0.0056591933,0.012514292,0.000089608155,0.000042751675,0.0005405452,0.0011087995,0.000068117384,0.0073708007],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99970883,0.000067250854,0.000025499754,0.00006587134,0.00007222432,0.00006032376],"domain_scores_gemma":[0.99976975,0.0000565857,0.00006131259,0.00005591995,0.000016928341,0.000039542196],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047614967,0.0007753773,0.0005051914,0.000797091,0.00024070573,0.0005111953,0.00058448437,0.00053483073,0.0014814262],"category_scores_gemma":[0.00021245565,0.00035768925,0.00050211366,0.00033287454,0.0005786085,0.0004547817,0.0002512795,0.0016175691,0.0005641556],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006336827,0.00044530502,0.00016664734,0.00009428542,0.000017153105,0.00014405341,0.00003550967,0.00028275876,0.9945315,0.0005904548,0.00018630504,0.0028722223],"study_design_scores_gemma":[0.00014651011,0.0018816543,0.0005917619,0.000014925074,0.000037287376,0.0004625546,0.000018622355,0.0022080203,0.98970115,0.000120074714,0.004809268,0.000008157842],"about_ca_topic_score_codex":0.0009894106,"about_ca_topic_score_gemma":0.0008585774,"teacher_disagreement_score":0.0014814262,"about_ca_system_score_codex":0.00071017,"about_ca_system_score_gemma":0.0005411145,"threshold_uncertainty_score":0.0051527023},"labels":[],"label_agreement":null},{"id":"W2020835690","doi":"10.1089/cbr.2011.1148","title":"<i>In Vitro</i> and <i>In Vivo</i> Evaluation of [ <sup>18</sup> F]F-GAZ, a Novel Oxygen-Mimetic Azomycin-Glucose Conjugate, for Imaging Hypoxic Tumor","year":2012,"lang":"en","type":"article","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation; University of Alberta","funders":"Canadian Institutes of Health Research; Alberta Cancer Foundation","keywords":"Biodistribution; In vivo; Chemistry; Imaging agent; In vitro; Excretion; Hypoxia (environmental); Radiochemistry; Nuclear medicine; Oxygen; Medicine; Biochemistry; Biology","score_opus":0.03236497458322271,"score_gpt":0.3457569114464636,"score_spread":0.31339193686324085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020835690","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9719141,0.010330792,0.014259102,0.00026910493,0.000047958754,0.00010778296,0.00027556435,0.00011587599,0.002679726],"genre_scores_gemma":[0.97797316,0.006740132,0.012757246,0.00017722115,0.00004466547,0.0000986326,0.00067646697,0.000052632047,0.0014799222],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999856,0.00006749728,0.000006414458,0.000022212947,0.000026345064,0.000021452463],"domain_scores_gemma":[0.9998474,0.000041096504,0.000047303816,0.0000122181755,0.000028812794,0.000023063714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033394762,0.0005421907,0.00028249103,0.00015606389,0.00014469176,0.00027289332,0.0002974663,0.00050089153,0.0005359757],"category_scores_gemma":[0.00025811294,0.00018251534,0.00022189615,0.00012913562,0.00026933276,0.00036189007,0.00010504703,0.00040925722,0.00024923278],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041172796,0.00006535989,0.00036744343,0.00008122325,0.000009931131,0.00006950354,0.00001760193,0.00047555455,0.99518436,0.00004891734,0.000078895406,0.0031893654],"study_design_scores_gemma":[0.000022849414,0.0016152272,0.001500174,0.0000041874414,0.00003731112,0.00039678393,0.000016849403,0.0011285857,0.99394196,0.000012846741,0.0013168883,0.0000063473462],"about_ca_topic_score_codex":0.0011448757,"about_ca_topic_score_gemma":0.0009325209,"teacher_disagreement_score":0.0011448757,"about_ca_system_score_codex":0.0003133675,"about_ca_system_score_gemma":0.00018139424,"threshold_uncertainty_score":0.0022764206},"labels":[],"label_agreement":null},{"id":"W2021997973","doi":"10.1089/cbr.2007.0430","title":"<i>Update:</i> Peptide Motifs for Insertion of Radiolabeled Biomolecules into Cells and Routing to the Nucleus for Cancer Imaging or Radiotherapeutic Applications","year":2008,"lang":"en","type":"review","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Cytoplasm; Cancer cell; Nucleus; Internalization; Chemistry; Peptide; Cell biology; Intracellular; Cell; Biophysics; Biochemistry; Cancer; Biology; Genetics","score_opus":0.06785277283146808,"score_gpt":0.4421922385253275,"score_spread":0.37433946569385945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021997973","genre_codex":"editorial","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0075256648,0.1367423,0.019470045,0.16303061,0.333935,0.0018694022,0.009930685,0.010717402,0.31677896],"genre_scores_gemma":[0.021518633,0.14553094,0.03443374,0.19603837,0.098985866,0.0025393125,0.015553645,0.0021933196,0.48320618],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989503,0.00008752765,0.000089757516,0.0000815027,0.0006749428,0.000115974435],"domain_scores_gemma":[0.996624,0.00040900675,0.0003272332,0.00013515927,0.0018054368,0.0006992181],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001694997,0.0015992327,0.0010330264,0.0013771226,0.00083549944,0.0029038258,0.0027899568,0.0068737348,0.02878112],"category_scores_gemma":[0.0029984072,0.00063872983,0.00094036217,0.0011354046,0.00078846794,0.0024704905,0.0009134193,0.0051173717,0.030170452],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010916119,0.00007812633,0.00011142168,0.0005624828,0.00001830666,0.00015037402,0.000013249994,0.00011752986,0.00719889,0.0007583469,0.94828695,0.04259521],"study_design_scores_gemma":[0.000027685062,0.000077803445,0.0002597711,0.00008978347,0.0000136726185,0.00019486352,0.000009043093,0.00012391288,0.0024648085,0.00022312895,0.9965004,0.000015092066],"about_ca_topic_score_codex":0.0024759516,"about_ca_topic_score_gemma":0.008640579,"teacher_disagreement_score":0.02878112,"about_ca_system_score_codex":0.0016067184,"about_ca_system_score_gemma":0.0020012856,"threshold_uncertainty_score":0.09628242},"labels":[],"label_agreement":null},{"id":"W2022046169","doi":"10.1089/cbr.2006.21.613","title":"Human Dendritic Cells Engineered to Express Alpha Tumor Necrosis Factor Maintain Cellular Maturation and T-Cell Stimulation Capacity","year":2006,"lang":"en","type":"article","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatchewan Cancer Agency","funders":"","keywords":"Tumor necrosis factor alpha; Ex vivo; Immunology; Dendritic cell; Immune system; Cytokine; Peripheral blood mononuclear cell; Biology; Granulocyte macrophage colony-stimulating factor; In vivo; Cancer research; Medicine; In vitro","score_opus":0.018775526164473415,"score_gpt":0.28255336468414033,"score_spread":0.2637778385196669,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022046169","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9809925,0.004326849,0.011608344,0.00008961225,0.000096229895,0.00012851293,0.00087618444,0.000093012684,0.0017887241],"genre_scores_gemma":[0.9873241,0.0016581875,0.007016308,0.00007436609,0.00002560214,0.00006915723,0.0014434335,0.000024382203,0.0023642674],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998554,0.00002237409,0.000019267742,0.000034482175,0.000037635073,0.000030699426],"domain_scores_gemma":[0.999835,0.000033068354,0.000039093087,0.00003534951,0.00003770774,0.00001982867],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017015675,0.00022161176,0.00028117918,0.00009364191,0.000079670885,0.00030887267,0.00012729417,0.00018415225,0.00054720463],"category_scores_gemma":[0.0002384694,0.00009517238,0.0001777453,0.00015967379,0.00013559395,0.000142418,0.000116038886,0.00041195218,0.0004092133],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014786,0.00003446861,0.00026239836,0.00003116615,0.000003663596,0.000029216273,0.000014424273,0.00011714126,0.9973502,0.00007434499,0.000035690035,0.0018992337],"study_design_scores_gemma":[0.000025237592,0.00032179095,0.0010708759,0.000005136608,0.000019586161,0.0001921553,0.000007985211,0.00053448376,0.9927059,0.000039203842,0.005074071,0.0000035082512],"about_ca_topic_score_codex":0.00019518369,"about_ca_topic_score_gemma":0.00018789056,"teacher_disagreement_score":0.00054720463,"about_ca_system_score_codex":0.00018339718,"about_ca_system_score_gemma":0.00015282967,"threshold_uncertainty_score":0.0018305779},"labels":[],"label_agreement":null},{"id":"W2022046439","doi":"10.1089/cbr.2009.0714","title":"Tumor Necrosis Factor Gene-Engineered J558 Tumor Cell–Released Exosomes Stimulate Tumor Antigen P1A-Specific CD8 <sup>+</sup> CTL Responses and Antitumor Immunity","year":2010,"lang":"en","type":"article","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatchewan Cancer Agency","funders":"Canadian Institutes of Health Research","keywords":"CTL*; Cytotoxic T cell; CD8; Tumor antigen; Molecular biology; Immune system; Antigen; Tumor necrosis factor alpha; Biology; T cell; Immunology; Immunotherapy; Biochemistry","score_opus":0.018511428718595187,"score_gpt":0.30249453200982324,"score_spread":0.28398310329122806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022046439","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983223,0.00025545663,0.0006876621,0.000031157546,0.00001857171,0.000015199999,0.00008499567,0.00001539072,0.00056931004],"genre_scores_gemma":[0.99756587,0.00020589004,0.00093827356,0.000041413517,0.000012190016,0.000019910312,0.00024837328,0.00000899856,0.0009589059],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998572,0.00002219108,0.000017132996,0.000028389915,0.000026697393,0.00004835472],"domain_scores_gemma":[0.99991274,0.000023262623,0.000025479987,0.000010825627,0.0000072026046,0.000020533931],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000110402434,0.0003997729,0.00019976209,0.000098561104,0.000066552835,0.00031671792,0.000078696445,0.00021818276,0.00077897107],"category_scores_gemma":[0.00010820443,0.000091154885,0.00027694547,0.000084014144,0.0001502367,0.00029931654,0.00018648164,0.00057438115,0.0002796028],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024374314,0.000081155136,0.00019458061,0.000024988376,0.000004824062,0.000040803003,0.000011372774,0.00006649112,0.99827874,0.00004736844,0.00003417308,0.0009717028],"study_design_scores_gemma":[0.00003089228,0.0008009433,0.0030649595,0.0000046592395,0.000015088999,0.00018044766,0.000025906485,0.0011348276,0.99379647,0.0000316006,0.0009113358,0.0000029966632],"about_ca_topic_score_codex":0.00011957166,"about_ca_topic_score_gemma":0.00014496657,"teacher_disagreement_score":0.00077897107,"about_ca_system_score_codex":0.00018962754,"about_ca_system_score_gemma":0.000102221835,"threshold_uncertainty_score":0.002605915},"labels":[],"label_agreement":null},{"id":"W2024836545","doi":"10.1089/1084978041424990","title":"Engineered Fusion Hybrid Vaccine of IL-18 Gene-Modified Tumor Cells and Dendritic Cells Induces Enhanced Antitumor Immunity","year":2004,"lang":"en","type":"article","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatchewan Cancer Agency","funders":"","keywords":"CTL*; Immunotherapy; Immune system; Antigen; Dendritic cell; Immunology; Cell fusion; Immunization; Biology; Interleukin 12; Cytotoxic T cell; Cell culture; In vitro; CD8","score_opus":0.02081627550124255,"score_gpt":0.3005928175866874,"score_spread":0.27977654208544483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024836545","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99421847,0.00082118815,0.0040824297,0.000045297256,0.000057712954,0.000035924884,0.000075505406,0.00005894763,0.0006046161],"genre_scores_gemma":[0.9956729,0.00036841523,0.0030315854,0.00004570907,0.000021930173,0.000032791213,0.0001806741,0.000008557338,0.00063745875],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998292,0.000018405064,0.000014583228,0.000038905782,0.000043425764,0.000055513327],"domain_scores_gemma":[0.9999306,0.0000105715935,0.000025794938,0.0000066870653,0.0000083256,0.000018039551],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010149686,0.00045762162,0.00039121782,0.00014529552,0.000053063643,0.0002552465,0.00015897662,0.0003504695,0.0005516249],"category_scores_gemma":[0.0000869939,0.00012555247,0.0002678424,0.00010854257,0.00012960105,0.00022552836,0.0001910347,0.00054455653,0.00019316436],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000128441,0.000080765734,0.00019292478,0.00003658903,0.000009961435,0.000034566452,0.000006878954,0.00020817533,0.99790144,0.00008019454,0.000024570782,0.0012954453],"study_design_scores_gemma":[0.00007825303,0.0015130923,0.0015141916,0.000007232796,0.00006118024,0.00032100422,0.000015649144,0.0029641145,0.9908484,0.00005854033,0.0026130793,0.0000053441777],"about_ca_topic_score_codex":0.00011251334,"about_ca_topic_score_gemma":0.00015408882,"teacher_disagreement_score":0.0005516249,"about_ca_system_score_codex":0.0001979132,"about_ca_system_score_gemma":0.00015861701,"threshold_uncertainty_score":0.0018453002},"labels":[],"label_agreement":null},{"id":"W2027381742","doi":"10.1089/cbr.2010.0793","title":"Radiotracers for Noninvasive Molecular Imaging of Tumor Cell Death","year":2010,"lang":"en","type":"review","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Killam Trusts; Cancer Research Institute","keywords":"Programmed cell death; Autophagy; Apoptosis; Medicine; Mechanism (biology); Clinical trial; Cancer; Molecular imaging; Cancer research; Cell; Neuroscience; Bioinformatics; Pathology; Biology; In vivo; Internal medicine","score_opus":0.03000672279274699,"score_gpt":0.37455548626592566,"score_spread":0.3445487634731787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027381742","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003549039,0.9947948,0.0017265223,0.0001740863,0.00018681986,0.000020917416,0.00002897818,0.000028299506,0.002684748],"genre_scores_gemma":[0.0023053272,0.9919579,0.0022442096,0.00026150708,0.0001179762,0.00005300036,0.000085471984,0.000009445754,0.0029652596],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997254,0.000041813128,0.000019065847,0.00005313999,0.00012936491,0.000031252228],"domain_scores_gemma":[0.9997255,0.00012616086,0.000041012212,0.000014285642,0.00007118835,0.000021879607],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081357703,0.0013549828,0.0018168809,0.0026370839,0.00029642758,0.00094717136,0.0014378327,0.0017624216,0.0035007994],"category_scores_gemma":[0.00055197836,0.00055782986,0.0005679211,0.0025171451,0.00076436123,0.0016566071,0.0007621087,0.002535835,0.0044271275],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010435502,0.0001331535,0.00020968453,0.010229842,0.000094995485,0.0005107867,0.00008556042,0.0008629664,0.04600255,0.011856315,0.01896386,0.91094595],"study_design_scores_gemma":[0.000028593668,0.00010512238,0.00046180372,0.00079380133,0.0000707107,0.002565114,0.00003982309,0.00024616125,0.013160874,0.002672933,0.9798196,0.000035405476],"about_ca_topic_score_codex":0.0010998484,"about_ca_topic_score_gemma":0.0013461591,"teacher_disagreement_score":0.0035007994,"about_ca_system_score_codex":0.001158521,"about_ca_system_score_gemma":0.0008923724,"threshold_uncertainty_score":0.011711299},"labels":[],"label_agreement":null},{"id":"W2029424531","doi":"10.1089/cbr.2012.1196","title":"Positron-Emission Tomography Imaging of the TSPO with [ <sup>18</sup> F]FEPPA in a Preclinical Breast Cancer Model","year":2013,"lang":"en","type":"article","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto; Centre for Addiction and Mental Health","funders":"","keywords":"Translocator protein; Biodistribution; Radiosynthesis; Positron emission tomography; Ex vivo; In vivo; Preclinical imaging; Nuclear medicine; Breast cancer; Molecular imaging; Imaging agent; Chemistry; Medicine; Radioligand; Cancer research; Cancer; Pathology; Receptor; Internal medicine; Biology; Neuroinflammation","score_opus":0.029773001461898912,"score_gpt":0.3653497138057176,"score_spread":0.3355767123438187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029424531","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.968593,0.0033824288,0.024526613,0.00018406869,0.000021155314,0.000072375704,0.0004197172,0.00026007355,0.0025407367],"genre_scores_gemma":[0.9559084,0.0031988032,0.03530571,0.00009719408,0.000020330403,0.00014871849,0.0006963705,0.00009246126,0.0045318836],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99994123,0.000013485514,0.0000024896847,0.000013532962,0.000016591799,0.0000126767945],"domain_scores_gemma":[0.9999454,0.000011223868,0.000016623228,0.0000053590807,0.000012116514,0.000009240659],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001876281,0.00030070293,0.00021067105,0.00015673348,0.000087815715,0.00014429136,0.00020257127,0.0003268191,0.00079820224],"category_scores_gemma":[0.000101492216,0.00017205466,0.00012502978,0.00012139965,0.00014684041,0.00018013429,0.00009806059,0.00025440878,0.00034843615],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012752904,0.000011012743,0.00012926412,0.000026782935,0.0000042058487,0.000047700138,0.000008551488,0.00019163851,0.998295,0.000042864853,0.000056323403,0.0010591634],"study_design_scores_gemma":[0.000029298657,0.0006303186,0.0029952838,0.0000065776503,0.000032314518,0.00068738026,0.00002334158,0.0026828714,0.98873,0.00003499715,0.0041400325,0.0000075129087],"about_ca_topic_score_codex":0.0011832989,"about_ca_topic_score_gemma":0.0013153001,"teacher_disagreement_score":0.0011832989,"about_ca_system_score_codex":0.00018164866,"about_ca_system_score_gemma":0.0001801336,"threshold_uncertainty_score":0.0026702285},"labels":[],"label_agreement":null},{"id":"W2032007643","doi":"10.1089/cbr.2008.0582","title":"Adenovirus-Mediated ING4 Expression Suppresses Pancreatic Carcinoma Cell Growth via Induction of Cell-Cycle Alteration, Apoptosis, and Inhibition of Tumor Angiogenesis","year":2009,"lang":"en","type":"article","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Cancer research; Transfection; Genetic enhancement; Biology; Cell cycle; Angiogenesis; Tumor suppressor gene; Cell growth; Apoptosis; Pancreatic tumor; Viral vector; Growth inhibition; Pancreatic cancer; Cell culture; Carcinogenesis; Cancer; Gene; Recombinant DNA","score_opus":0.012488129391987913,"score_gpt":0.29454405836041986,"score_spread":0.28205592896843196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032007643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941677,0.0013332409,0.0025192997,0.00007377211,0.000024664414,0.000022540607,0.00012557977,0.00009225754,0.0016409085],"genre_scores_gemma":[0.9906943,0.0015539078,0.0036911431,0.000029636789,0.00001145583,0.00003141657,0.00042400142,0.000013823298,0.003550239],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999261,0.000016608312,0.0000066617013,0.000010755641,0.000018719533,0.000021147074],"domain_scores_gemma":[0.9999478,0.000011488506,0.000014812335,0.00001022034,0.000005066813,0.000010571583],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011458189,0.00030440313,0.00017513032,0.00018994059,0.00008614002,0.00017899009,0.00014006748,0.00012381666,0.0005550084],"category_scores_gemma":[0.00008434061,0.000101384074,0.00015882359,0.00011423714,0.00022178762,0.000098805016,0.00010392446,0.00037635115,0.00017582101],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000089594345,0.000040597297,0.0001847961,0.000024279327,0.0000029753426,0.000032966487,0.000007712029,0.000104695966,0.99769646,0.00015477459,0.000035601955,0.0016255606],"study_design_scores_gemma":[0.000025798743,0.00028795254,0.0011514302,0.0000026369705,0.000011385517,0.0001416219,0.000010513035,0.0010084899,0.99456257,0.000058584235,0.0027370674,0.0000019741901],"about_ca_topic_score_codex":0.00050723244,"about_ca_topic_score_gemma":0.00050389266,"teacher_disagreement_score":0.0005550084,"about_ca_system_score_codex":0.00030038028,"about_ca_system_score_gemma":0.00027431315,"threshold_uncertainty_score":0.0021793842},"labels":[],"label_agreement":null},{"id":"W2034006621","doi":"10.1089/cbr.2005.20.379","title":"Pretargeted Radioimmunotherapy (RIT) with a Novel Anti-TAG-72 Fusion Protein","year":2005,"lang":"en","type":"article","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research & Development Corporation","funders":"National Center for Research Resources; National Cancer Institute; National Institutes of Health","keywords":"Radioimmunotherapy; DOTA; Medicine; Nuclear medicine; Pretargeting; Dosimetry; Pharmacology; Chemistry; Antibody; Immunology; Chelation; Monoclonal antibody","score_opus":0.028959659007428747,"score_gpt":0.34908118884797795,"score_spread":0.3201215298405492,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034006621","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99445057,0.0014817402,0.002723969,0.00006300053,0.000031356296,0.00015059047,0.00008470221,0.00013037777,0.00088371057],"genre_scores_gemma":[0.99553406,0.00059814035,0.001975984,0.000095437994,0.000022712871,0.00014817688,0.00034230782,0.00001602609,0.0012672535],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99980897,0.00003726974,0.000006932143,0.000042613006,0.000042988937,0.000061247316],"domain_scores_gemma":[0.99992394,0.000012991952,0.000023733539,0.00001234406,0.0000058052756,0.000021174777],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019191306,0.00044239385,0.0005669135,0.00012621435,0.00013863586,0.00034228104,0.00029178927,0.0004505483,0.0011798302],"category_scores_gemma":[0.00017344902,0.00012193833,0.00027459365,0.0001579737,0.00030778005,0.00024965373,0.00022697778,0.0007838842,0.00033122272],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013796552,0.004407383,0.0039839856,0.00026227863,0.00014572062,0.0007552943,0.000100851124,0.0033482502,0.88204354,0.00071117346,0.001362894,0.08908215],"study_design_scores_gemma":[0.006367189,0.22378108,0.033637274,0.00003379325,0.0003801023,0.0077573746,0.000057840432,0.008516203,0.6978972,0.00026235025,0.021244818,0.00006470097],"about_ca_topic_score_codex":0.0004674334,"about_ca_topic_score_gemma":0.0008599525,"teacher_disagreement_score":0.0011798302,"about_ca_system_score_codex":0.00046498913,"about_ca_system_score_gemma":0.0002655443,"threshold_uncertainty_score":0.00394696},"labels":[],"label_agreement":null},{"id":"W2039880390","doi":"10.1089/cbr.2006.21.74","title":"Conversion of Tolerogenic CD4¯8¯ Dendritic Cells to Immunogenic Ones Inducing Efficient Antitumor Immunity","year":2006,"lang":"en","type":"article","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Saskatchewan Cancer Agency; University of Saskatchewan","funders":"","keywords":"Immune system; Dendritic cell; Ovalbumin; CTL*; Immunology; Antigen; Immunotherapy; Cytotoxic T cell; Biology; Immune tolerance; Immunity; Chemistry; Cell biology; CD8; In vitro; Biochemistry","score_opus":0.01673550027278966,"score_gpt":0.29668439818972897,"score_spread":0.27994889791693933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039880390","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951239,0.0009438176,0.002380057,0.00004477403,0.00005526072,0.000047264697,0.00021408932,0.000037057078,0.0011538118],"genre_scores_gemma":[0.9935494,0.0006788,0.0036714799,0.00006869079,0.000029713838,0.000079875506,0.00053711375,0.000021681879,0.0013632573],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99979526,0.00003914671,0.000030486908,0.00003525622,0.000050993145,0.000048794755],"domain_scores_gemma":[0.9998503,0.000039700197,0.000033380707,0.000024137187,0.000024933683,0.000027552864],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017672543,0.0002532027,0.0002593654,0.00016411627,0.00009492983,0.00033111856,0.00014617683,0.0001837469,0.0008964621],"category_scores_gemma":[0.00017198757,0.000121010395,0.0002114829,0.00013609252,0.00010461758,0.00015107564,0.00015994944,0.0005549502,0.00030215073],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049584964,0.000025213678,0.00015376015,0.000020427404,0.0000019831243,0.000028191429,0.000009225863,0.000030393378,0.9987214,0.000023893741,0.000011002473,0.0009248905],"study_design_scores_gemma":[0.000015867347,0.0002806799,0.0026112713,0.000006433735,0.00001745721,0.00013341877,0.000019430903,0.00032478056,0.9942748,0.000039497645,0.0022731787,0.0000031054888],"about_ca_topic_score_codex":0.00010564111,"about_ca_topic_score_gemma":0.00018457642,"teacher_disagreement_score":0.0008964621,"about_ca_system_score_codex":0.00015934829,"about_ca_system_score_gemma":0.00012301534,"threshold_uncertainty_score":0.002998948},"labels":[],"label_agreement":null},{"id":"W2045316963","doi":"10.1089/108497804773391757","title":"Molecular Imaging and Treatment of Malignant Gliomas Following Adenoviral Transfer of the Herpes Simplex Virus-Thymidine Kinase Gene and the Somatostatin Receptor Subtype 2 Gene","year":2004,"lang":"en","type":"article","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Somatostatin receptor; Genetic enhancement; Herpes simplex virus; Multiplicity of infection; Somatostatin receptor 2; Glioma; Somatostatin; Thymidine kinase; Cancer research; Cell culture; Radionuclide therapy; In vivo; Biology; Molecular biology; Virology; Medicine; Virus; Internal medicine; Endocrinology; Gene; Biochemistry","score_opus":0.01796847720985809,"score_gpt":0.32318984023961256,"score_spread":0.30522136302975444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045316963","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9809585,0.009345879,0.006032295,0.0001043916,0.00007523443,0.000058372265,0.0001360917,0.00009523682,0.0031939184],"genre_scores_gemma":[0.98807496,0.0038455091,0.0051192543,0.000045378823,0.000016465712,0.00004926929,0.00023856347,0.000017451137,0.0025932582],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999304,0.000012159578,0.0000040430646,0.000012328974,0.000018803476,0.000022247077],"domain_scores_gemma":[0.9999852,0.0000046846612,0.0000030129388,0.0000019889371,0.0000019405227,0.0000032553535],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010588557,0.00024547993,0.00017548051,0.0001241819,0.00007871806,0.00017309678,0.00013711557,0.00023627612,0.00077449117],"category_scores_gemma":[0.00006909573,0.000082284554,0.00016617785,0.00010898251,0.00013961903,0.00015067757,0.00007880894,0.0002261955,0.00017253176],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001961384,0.000041399668,0.000097877986,0.000079328136,0.0000050796566,0.00007636592,0.000020398793,0.00011470411,0.9939329,0.0001467782,0.00006180733,0.005227263],"study_design_scores_gemma":[0.000028671753,0.00082894356,0.0022573816,0.000004865724,0.000019707068,0.00038738313,0.00001886781,0.0009578201,0.99156195,0.00004133795,0.003887699,0.0000053079966],"about_ca_topic_score_codex":0.0011488271,"about_ca_topic_score_gemma":0.000816344,"teacher_disagreement_score":0.0011488271,"about_ca_system_score_codex":0.00023123444,"about_ca_system_score_gemma":0.0001513636,"threshold_uncertainty_score":0.0025909543},"labels":[],"label_agreement":null},{"id":"W2046217321","doi":"10.1089/cbr.2005.20.290","title":"Molecular and Immunophenotypical Characterization of Progressive and Regressive Leukemia Cell Lines","year":2005,"lang":"en","type":"article","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; University of Saskatchewan; Saskatchewan Cancer Agency","funders":"Canadian Institutes of Health Research; Health Canada","keywords":"Biology; Cell culture; Cancer research; Mastocytoma; Immunophenotyping; Molecular biology; Tumor progression; Fibrosarcoma; Gene; Immunology; Flow cytometry; Tumor cells; Genetics","score_opus":0.011398879246882761,"score_gpt":0.2956756507662672,"score_spread":0.2842767715193844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046217321","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99327385,0.0005487196,0.0036155004,0.00002604127,0.000007986062,0.00007158104,0.0011862051,0.000045234327,0.0012248851],"genre_scores_gemma":[0.9881513,0.00066914246,0.0046743616,0.000063242216,0.00001892362,0.00015441231,0.0043173824,0.000021946928,0.0019291235],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99980897,0.000018616349,0.000020491389,0.000049532562,0.00006393274,0.00003849852],"domain_scores_gemma":[0.9997912,0.000047232817,0.000048146398,0.000036993362,0.00003378592,0.00004266149],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000094953466,0.00024101876,0.00016109388,0.00058172614,0.00013925579,0.00026935918,0.00013476654,0.00019559373,0.00084930065],"category_scores_gemma":[0.00016594525,0.00010762322,0.00018104054,0.00031601574,0.00014525784,0.00013506487,0.00015008221,0.0003473354,0.00040469726],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007653978,0.000027373442,0.0015886356,0.000011552793,0.0000029729022,0.00006324449,0.000021102187,0.000036311914,0.9971891,0.00005321801,0.000015659096,0.00091432873],"study_design_scores_gemma":[0.000047177953,0.0011867625,0.120905854,0.000008726752,0.00005947959,0.0015581774,0.0002278892,0.002250217,0.8689288,0.00013982151,0.004672192,0.000015014047],"about_ca_topic_score_codex":0.00048147666,"about_ca_topic_score_gemma":0.00054774916,"teacher_disagreement_score":0.00084930065,"about_ca_system_score_codex":0.00012203219,"about_ca_system_score_gemma":0.00012874254,"threshold_uncertainty_score":0.0028412342},"labels":[],"label_agreement":null},{"id":"W2051614202","doi":"10.1089/cbr.2010.0806","title":"A Case of Rituximab-Induced Hepatitis","year":2010,"lang":"en","type":"article","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"","keywords":"Rituximab; Medicine; Hepatitis; Etiology; Immunology; Hepatitis C; Virology; Internal medicine; Lymphoma","score_opus":0.034307700647676305,"score_gpt":0.38102177134243403,"score_spread":0.34671407069475774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051614202","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93630457,0.012297932,0.0072087795,0.0053008893,0.0010635512,0.0002622107,0.00024745005,0.0005845023,0.03673011],"genre_scores_gemma":[0.99294865,0.001343214,0.0011733397,0.0013411966,0.00097337266,0.00003274796,0.00007860744,0.000043184253,0.0020656788],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99849784,0.000308755,0.00014372772,0.000268015,0.00019532768,0.00058640994],"domain_scores_gemma":[0.99642193,0.0012521462,0.0005662265,0.00057646056,0.00019690486,0.0009863616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008617813,0.0027015682,0.0015706838,0.0032825307,0.0036439523,0.0023786,0.0016821033,0.008405514,0.003409866],"category_scores_gemma":[0.006138834,0.0018514971,0.0017690667,0.0021941816,0.001977663,0.0021684016,0.0022448075,0.0048989113,0.0020176233],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000036761987,0.00005993945,0.002184333,0.000020070845,0.000010024897,0.995996,0.0001514112,0.00005096095,0.00044982164,0.00016635565,0.00017719413,0.0006971311],"study_design_scores_gemma":[0.000025789073,0.00008245675,0.0017981223,0.000009816754,0.000013053098,0.99680626,0.00006180462,0.0001661978,0.0003508575,0.000110553665,0.00056677125,0.000008433471],"about_ca_topic_score_codex":0.0014312998,"about_ca_topic_score_gemma":0.0012363507,"teacher_disagreement_score":0.008405514,"about_ca_system_score_codex":0.0016308546,"about_ca_system_score_gemma":0.00080789917,"threshold_uncertainty_score":0.011832774},"labels":[],"label_agreement":null},{"id":"W2059472076","doi":"10.1089/cbr.2004.19.669","title":"The Immunoreactivity of Radiolabeled Antibodies—Its Impact on Tumor Targeting and Strategies for Preservation","year":2004,"lang":"en","type":"editorial","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Radioimmunotherapy; Trastuzumab; Monoclonal antibody; Cancer research; Breast cancer; Cancer; Medicine; Antibody; Molecular imaging; In vivo; Internal medicine; Biology; Immunology","score_opus":0.026490259766567915,"score_gpt":0.4283959741969743,"score_spread":0.40190571443040635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059472076","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00020400225,0.06199189,0.00065432274,0.034175843,0.900847,0.0000163366,0.000033468074,0.00006131535,0.0020157932],"genre_scores_gemma":[0.0029265499,0.052796945,0.0005923938,0.043029297,0.8814102,0.000038558348,0.00004845266,0.000053783206,0.019103901],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99815744,0.00036880418,0.00030670932,0.00025593917,0.00079299195,0.00011810284],"domain_scores_gemma":[0.99524504,0.0022882991,0.00035253481,0.00012914452,0.0015508833,0.0004341557],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038958313,0.0027026203,0.0027342637,0.0021078987,0.001315793,0.0033597127,0.0031397617,0.012803296,0.0032628325],"category_scores_gemma":[0.006678962,0.0011157639,0.0020709895,0.0010104269,0.0025680268,0.0031736451,0.0010178233,0.01753356,0.0024982067],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024295121,0.00003590485,0.000052178413,0.00089972577,0.00009347614,0.0005335235,0.000024061781,0.00010190796,0.001534903,0.0014828185,0.9662597,0.028738774],"study_design_scores_gemma":[0.00009146701,0.00008003178,0.00020871994,0.00024464837,0.00016009295,0.00085185026,0.000016956363,0.0001612978,0.0011545786,0.0009835814,0.99602133,0.000025421328],"about_ca_topic_score_codex":0.0011869096,"about_ca_topic_score_gemma":0.002648923,"teacher_disagreement_score":0.012803296,"about_ca_system_score_codex":0.002395281,"about_ca_system_score_gemma":0.0013011731,"threshold_uncertainty_score":0.020603359},"labels":[],"label_agreement":null},{"id":"W2067326341","doi":"10.1089/cbr.2012.1200.271","title":"Preclinical Evaluation of VB6-845: An Anti-EpCAM Immunotoxin with Reduced Immunogenic Potential","year":2012,"lang":"en","type":"article","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Toxin Mechanisms and Immunotoxins","field":"Immunology and Microbiology","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Viventia Bio (Canada)","funders":"","keywords":"Immunotoxin; Epithelial cell adhesion molecule; Pharmacology; Medicine; Immunotherapy; Adverse effect; Pharmacokinetics; Antibody; Immunology; Monoclonal antibody; Immune system","score_opus":0.06114198218091945,"score_gpt":0.3889204511167967,"score_spread":0.32777846893587725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067326341","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99185354,0.0019007531,0.0035016825,0.00012537006,0.000051943556,0.0003637975,0.0006852657,0.0000907315,0.0014270551],"genre_scores_gemma":[0.98960364,0.002315732,0.0026483098,0.00013960584,0.000024985135,0.00026971547,0.0015000313,0.000022901164,0.0034750907],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998474,0.000026721838,0.00000859115,0.000030474488,0.000036761212,0.00005013299],"domain_scores_gemma":[0.9998511,0.000020412203,0.00004274819,0.000012011542,0.000032339773,0.000041340016],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042790853,0.00060138264,0.0005408414,0.00033498523,0.00017369546,0.00031807143,0.0005096161,0.0005636463,0.0015305381],"category_scores_gemma":[0.00021921472,0.00015708359,0.00033250218,0.0002129186,0.00023662984,0.0002714508,0.00019409708,0.001112522,0.00027743835],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00174652,0.00311924,0.00038389635,0.00024266986,0.00006155007,0.0001330599,0.00005631618,0.0014998799,0.9791109,0.00019238773,0.00040376862,0.01304985],"study_design_scores_gemma":[0.00082952896,0.10458255,0.004885175,0.00004512779,0.00025457292,0.0005048208,0.000060573268,0.0023929356,0.8774614,0.00015077252,0.008811778,0.00002078048],"about_ca_topic_score_codex":0.0007812544,"about_ca_topic_score_gemma":0.0010057214,"teacher_disagreement_score":0.0015305381,"about_ca_system_score_codex":0.0003732524,"about_ca_system_score_gemma":0.00042339833,"threshold_uncertainty_score":0.0051200986},"labels":[],"label_agreement":null},{"id":"W2068717865","doi":"10.1089/cbr.2010.0778","title":"Tumor-Suppressive Effect of Adenovirus-Mediated Inhibitor of Growth 4 Gene Transfer in Breast Carcinoma Cells <i>In Vitro</i> and <i>In Vivo</i>","year":2010,"lang":"en","type":"article","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Cancer research; Breast carcinoma; Biology; Apoptosis; Downregulation and upregulation; Tumor suppressor gene; In vivo; Nude mouse; Breast cancer; Cancer; Carcinogenesis; Gene","score_opus":0.006494608147965627,"score_gpt":0.2650902706782928,"score_spread":0.2585956625303272,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068717865","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960731,0.0012970436,0.0009974617,0.00006256981,0.00003886419,0.000019675326,0.00014671026,0.000072039395,0.0012925033],"genre_scores_gemma":[0.99445915,0.0012388137,0.0013833232,0.0000403165,0.000010707563,0.000035559508,0.0006151986,0.000014027455,0.0022030035],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999205,0.000016848071,0.0000074610793,0.000012833728,0.00001899756,0.000023417098],"domain_scores_gemma":[0.99994195,0.000016009553,0.000013360876,0.000010175126,0.000006970124,0.000011572825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013123725,0.00034704842,0.00017703288,0.00021215138,0.00009049458,0.00019655842,0.00014543899,0.00012752184,0.00078851264],"category_scores_gemma":[0.00008300353,0.00010926263,0.0002142043,0.000109470166,0.00015898027,0.000118975695,0.00008306497,0.000425635,0.0001731808],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018937506,0.00007207731,0.00014013067,0.000029888311,0.000005776458,0.00002494358,0.000012145684,0.000078019606,0.99816126,0.00007491382,0.000044913817,0.0011664476],"study_design_scores_gemma":[0.000020457002,0.0006981448,0.0009728774,0.0000026688658,0.000014920645,0.00007941941,0.000012809311,0.0007182491,0.99642414,0.000018422323,0.001035943,0.0000018665157],"about_ca_topic_score_codex":0.0011466241,"about_ca_topic_score_gemma":0.0007844734,"teacher_disagreement_score":0.0011466241,"about_ca_system_score_codex":0.00028287913,"about_ca_system_score_gemma":0.00028397594,"threshold_uncertainty_score":0.0026378036},"labels":[],"label_agreement":null},{"id":"W2068889233","doi":"10.1089/cbr.2006.21.225","title":"Oncolytic Adenovirus-Mediated E1A Gene Therapy Induces Tumor-Cell Apoptosis and Reduces Tumor Angiogenesis Leading to Inhibition of Hepatocellular Carcinoma Growth in Animal Model","year":2006,"lang":"en","type":"article","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Oncolytic virus; Cancer research; Survivin; Angiogenesis; Oncolytic adenovirus; Genetic enhancement; Downregulation and upregulation; Apoptosis; Hepatocellular carcinoma; Adenoviridae; Biology; Gene","score_opus":0.03281651847950419,"score_gpt":0.3200040272150378,"score_spread":0.2871875087355336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068889233","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9874111,0.003087427,0.007067177,0.00015727732,0.000052427597,0.00004440858,0.00019810568,0.00016618814,0.0018159439],"genre_scores_gemma":[0.99163646,0.0017070713,0.0031512799,0.000026996719,0.000011807745,0.00003682291,0.00031689476,0.000016991646,0.0030956408],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99987745,0.000032929212,0.000010450217,0.000020069496,0.000028766244,0.00003034915],"domain_scores_gemma":[0.99992967,0.0000155501,0.000018534622,0.000012666616,0.000009349901,0.000014281392],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022656654,0.00039343585,0.00033281173,0.00033844245,0.0001122842,0.00019417983,0.00015596882,0.00022340401,0.0010203345],"category_scores_gemma":[0.00010761861,0.0001399085,0.0001922911,0.00012323525,0.00031316947,0.00020815602,0.00009315455,0.00051969854,0.00026547164],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001316048,0.0000650311,0.000116783565,0.000033427987,0.000007124204,0.000030059995,0.00001032546,0.00006834589,0.9979832,0.00017720275,0.000040374067,0.0013364617],"study_design_scores_gemma":[0.000023071929,0.00035333837,0.00055972376,0.0000023552295,0.000013390489,0.00010549363,0.0000066446146,0.00060622435,0.9970722,0.000034753422,0.0012208725,0.000001925629],"about_ca_topic_score_codex":0.000559512,"about_ca_topic_score_gemma":0.0005498677,"teacher_disagreement_score":0.0010203345,"about_ca_system_score_codex":0.0003010176,"about_ca_system_score_gemma":0.00021777436,"threshold_uncertainty_score":0.0034133792},"labels":[],"label_agreement":null},{"id":"W2070785431","doi":"10.1089/cbr.2009.0713","title":"Antiproliferative Effects of <sup>111</sup> In- or <sup>177</sup> Lu-DOTATOC on Cells Exposed to Low Multiplicity-of-Infection Double-Deleted Vaccinia Virus Encoding Somatostatin Subtype-2 Receptor","year":2010,"lang":"en","type":"article","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Bystander effect; Oncolytic virus; Multiplicity of infection; Cancer research; Vaccinia; Somatostatin receptor; Virus; Transfection; Medicine; Immune system; HEK 293 cells; Virology; Genetic enhancement; Cell culture; Biology; Receptor; Immunology; Internal medicine; Gene","score_opus":0.023050070907374366,"score_gpt":0.3488757189056654,"score_spread":0.325825647998291,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070785431","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99302226,0.0028370346,0.0013339863,0.00007374969,0.0000834346,0.000026636571,0.00036354357,0.000049423892,0.002209821],"genre_scores_gemma":[0.99102074,0.001432769,0.0032280115,0.00006120366,0.000022901437,0.000048726615,0.0008216687,0.000031518135,0.0033324554],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998871,0.000020867146,0.0000114264685,0.000017378263,0.00003170295,0.000031532887],"domain_scores_gemma":[0.99992204,0.00002877197,0.0000105396,0.00001194725,0.000014453127,0.000012298949],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009521068,0.00036007137,0.00040032342,0.00012374418,0.00012034642,0.00024147396,0.00015122221,0.00026434267,0.00117943],"category_scores_gemma":[0.00008026347,0.00013642579,0.00018757212,0.00014290882,0.00014297914,0.00012828862,0.000105323765,0.0004045883,0.0002803013],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010814798,0.000016750388,0.00010970941,0.000042637836,0.0000048356455,0.000030319527,0.0000132850655,0.000057885783,0.99835384,0.000045106997,0.00003362399,0.0011838621],"study_design_scores_gemma":[0.0000045831234,0.00018715288,0.0010202295,0.0000014093788,0.000009231608,0.000062436106,0.000007481219,0.00023557592,0.9976693,0.0000044933595,0.00079653575,0.0000014758209],"about_ca_topic_score_codex":0.0009555352,"about_ca_topic_score_gemma":0.0011920206,"teacher_disagreement_score":0.00117943,"about_ca_system_score_codex":0.00023279423,"about_ca_system_score_gemma":0.00024676023,"threshold_uncertainty_score":0.003945589},"labels":[],"label_agreement":null},{"id":"W2074270333","doi":"10.1089/cbr.2010.0813","title":"<i>In Vitro</i> Characterization of Two Novel Biodegradable Vectors for the Delivery of Radiolabeled Antisense Oligonucleotides","year":2010,"lang":"en","type":"article","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation; University of Alberta","funders":"Austrian Science Fund; Alberta Cancer Foundation","keywords":"Oligonucleotide; In vivo; In vitro; Chemistry; Intracellular; Biochemistry; Molecular biology; Biophysics; Biology; DNA","score_opus":0.018293639654973097,"score_gpt":0.3209996154214861,"score_spread":0.302705975766513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074270333","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97273964,0.0015220428,0.024331339,0.000076529795,0.000027640968,0.000073465446,0.0001987157,0.00010965942,0.0009209875],"genre_scores_gemma":[0.96636534,0.001641308,0.025585497,0.00005311114,0.0000195136,0.00014829819,0.0009737479,0.00006176566,0.005151429],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99979633,0.000040423085,0.000023119086,0.000033650136,0.00007017799,0.000036321686],"domain_scores_gemma":[0.9998161,0.000047194953,0.00006217057,0.000012381586,0.000037003494,0.000025146577],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000267206,0.00043548626,0.00021989552,0.00020020198,0.0001373917,0.0003563924,0.0001424252,0.00025906882,0.00047193805],"category_scores_gemma":[0.00039478144,0.00017980824,0.00021678349,0.00011578634,0.00022002531,0.00025729256,0.0001453878,0.00023945571,0.00023298098],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017597313,0.0000061996884,0.000034480687,0.000010570513,9.928245e-7,0.000017333812,0.000008349652,0.0000745726,0.9994491,0.000045487173,0.0000033877632,0.00033189575],"study_design_scores_gemma":[0.0000037574725,0.00014775786,0.00042850792,0.0000013552803,0.000004360628,0.00007614291,0.000004744385,0.0004994138,0.9982488,0.00001187847,0.00057044125,0.0000027568783],"about_ca_topic_score_codex":0.0009774258,"about_ca_topic_score_gemma":0.00082974264,"teacher_disagreement_score":0.0009774258,"about_ca_system_score_codex":0.00042791708,"about_ca_system_score_gemma":0.00030631956,"threshold_uncertainty_score":0.0031047463},"labels":[],"label_agreement":null},{"id":"W2081093096","doi":"10.1089/cbr.2000.15.7","title":"Radiobiology of Low-Dose-Rate Radiation Relevant to Radioimmunotherapy","year":2000,"lang":"en","type":"review","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Advanced Radiotherapy Techniques","field":"Physics and Astronomy","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation","funders":"","keywords":"Radioimmunotherapy; Radiobiology; Radiation therapy; Medicine; Dose rate; Nuclear medicine; Medical physics; External beam radiation; Oncology; Radiology; Immunology","score_opus":0.03380404522468958,"score_gpt":0.41157935055874234,"score_spread":0.3777753053340528,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081093096","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003404389,0.9959746,0.00047223788,0.00024157178,0.00026741598,0.000004937882,0.000004790416,0.000006947901,0.0026870673],"genre_scores_gemma":[0.002289537,0.9951202,0.00035806096,0.00024362559,0.00029924937,0.000009142717,0.000010091799,0.0000020200312,0.0016679505],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998311,0.000034520457,0.000017041522,0.000032147804,0.000071569266,0.000013718946],"domain_scores_gemma":[0.9998281,0.00007259309,0.000027073615,0.000009231622,0.000049261595,0.000013764156],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040421725,0.0007464845,0.0011678882,0.0014520668,0.00040704757,0.0010925813,0.00071629725,0.0010079858,0.0018663496],"category_scores_gemma":[0.0004032299,0.00023229336,0.00029391344,0.0018808014,0.0010307481,0.0014544867,0.0004930623,0.0015615588,0.0023255697],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000075392556,0.00012217619,0.0005198139,0.013476044,0.000048860064,0.00089923566,0.00027253674,0.0012827582,0.024482394,0.024382912,0.02162021,0.91281766],"study_design_scores_gemma":[0.000006641002,0.00006731853,0.0010326329,0.0011373324,0.000030397636,0.0030475834,0.00008597862,0.00010969684,0.002603992,0.0069968826,0.98486483,0.000016779039],"about_ca_topic_score_codex":0.0007103376,"about_ca_topic_score_gemma":0.0008401629,"teacher_disagreement_score":0.0018663496,"about_ca_system_score_codex":0.00079832703,"about_ca_system_score_gemma":0.0006469406,"threshold_uncertainty_score":0.006243527},"labels":[],"label_agreement":null},{"id":"W2095513250","doi":"10.1089/cbr.2011.1059","title":"Relevance of the POS-1 Orthotopic Model as an “Imaging Model” for <i>In Vivo</i> and Simultaneous Monitoring of Tumor Proliferation and Bone Remodeling in Osteosarcoma","year":2012,"lang":"en","type":"article","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Bone remodeling; In vivo; Osteosarcoma; Medicine; Cancer research; Pathology; Internal medicine; Biology","score_opus":0.022889260729722832,"score_gpt":0.33583147173478806,"score_spread":0.31294221100506525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095513250","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96014285,0.0016936046,0.033211607,0.0002734678,0.00010953133,0.0002255747,0.0008798694,0.00029662438,0.0031668048],"genre_scores_gemma":[0.96691287,0.0012326431,0.026845006,0.00011325515,0.000041870975,0.00028260442,0.0013695487,0.000104857325,0.0030973502],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996159,0.00009496194,0.000039347324,0.00010635517,0.000085034815,0.000058346668],"domain_scores_gemma":[0.9996401,0.00007905903,0.00011371087,0.00006481844,0.00004262783,0.000059703976],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070055353,0.000713541,0.00031199204,0.000429737,0.00019825241,0.0006085682,0.0004171368,0.00056027994,0.0011012428],"category_scores_gemma":[0.00021100735,0.00032559532,0.00033835956,0.00023061113,0.00043325202,0.0004933357,0.00026889733,0.00096019055,0.00043363005],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019157394,0.00008834596,0.00041299214,0.000035821988,0.0000032404514,0.00004755383,0.00001847082,0.00013218886,0.9977361,0.00013338302,0.000042726693,0.0011575733],"study_design_scores_gemma":[0.000023677783,0.0019115516,0.0040615704,0.000012881849,0.00002831323,0.0004955779,0.000050271643,0.0015052253,0.9901025,0.00008793615,0.0017093825,0.000011056112],"about_ca_topic_score_codex":0.0008302005,"about_ca_topic_score_gemma":0.0014582548,"teacher_disagreement_score":0.0011012428,"about_ca_system_score_codex":0.00029923924,"about_ca_system_score_gemma":0.00037730846,"threshold_uncertainty_score":0.0037049055},"labels":[],"label_agreement":null},{"id":"W2114783584","doi":"10.1089/cbr.2006.531","title":"Radiobiology of Systemic Radiation Therapy","year":2007,"lang":"en","type":"review","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Effects of Radiation Exposure","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Radiobiology; Medicine; Bystander effect; Radiation therapy; Clinical trial; Medical physics; Radionuclide therapy; Radioresistance; Systemic therapy; Clinical Practice; Mechanism (biology); Intensive care medicine; Cancer; Pathology; Nuclear medicine; Internal medicine; Immunology","score_opus":0.11488352530707849,"score_gpt":0.48632994069100177,"score_spread":0.3714464153839233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114783584","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016923854,0.7925713,0.1142176,0.010290308,0.0023671293,0.00017034347,0.0002085874,0.00033369826,0.06291719],"genre_scores_gemma":[0.32957006,0.59961396,0.0327036,0.008329289,0.0028691425,0.0005468903,0.0003559654,0.00027868882,0.025732316],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988887,0.0003828996,0.000060411407,0.0002457787,0.00033301333,0.00008923631],"domain_scores_gemma":[0.9992374,0.00034962693,0.00011167993,0.00008731626,0.00015450593,0.000059406226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015948998,0.00054667,0.0011584454,0.0010138545,0.00059476076,0.0025078477,0.0009931765,0.001353236,0.0027451722],"category_scores_gemma":[0.0011234671,0.0003498194,0.0005900293,0.0007209318,0.0031752805,0.001719761,0.0015406059,0.0026538293,0.0014602231],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035164793,0.00015265196,0.0040245107,0.008127986,0.00023966268,0.0013342933,0.001552863,0.010653083,0.20677796,0.34767404,0.0229605,0.39615068],"study_design_scores_gemma":[0.000045872603,0.0010064283,0.005713889,0.0014422457,0.00016223609,0.008160825,0.0007004432,0.0035972234,0.06989202,0.078905985,0.8302378,0.0001350962],"about_ca_topic_score_codex":0.0006238977,"about_ca_topic_score_gemma":0.00037125358,"teacher_disagreement_score":0.0027451722,"about_ca_system_score_codex":0.0017823254,"about_ca_system_score_gemma":0.0011337266,"threshold_uncertainty_score":0.012931764},"labels":[],"label_agreement":null},{"id":"W2116566846","doi":"10.1089/cbr.2007.0453","title":"Recombinant Human IL-24 Suppresses Lung Carcinoma Cell Growth via Induction of Cell Apoptosis and Inhibition of Tumor Angiogenesis","year":2008,"lang":"en","type":"article","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Angiogenesis; Lewis lung carcinoma; Cancer research; Biology; Peripheral blood mononuclear cell; Tumor necrosis factor alpha; In vivo; Transfection; Apoptosis; Cell culture; In vitro; Molecular biology; Immunology; Cancer; Metastasis","score_opus":0.027933573863687694,"score_gpt":0.31494605561314903,"score_spread":0.28701248174946137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116566846","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883944,0.0045578056,0.0045420914,0.00014194839,0.00006181615,0.000055036402,0.00027961042,0.00020581523,0.0017614596],"genre_scores_gemma":[0.9936148,0.0012460015,0.0025381418,0.0000446089,0.000021587055,0.000046201552,0.0004308157,0.000014132329,0.002043795],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998938,0.000028713512,0.00000911631,0.000014364267,0.000029048986,0.000025037732],"domain_scores_gemma":[0.99993026,0.00001857388,0.00001736975,0.000011591467,0.0000073192064,0.0000149041925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001204006,0.00029877626,0.00021094599,0.00016609262,0.00007720557,0.00021390223,0.00014162227,0.000141955,0.0010771126],"category_scores_gemma":[0.00010926836,0.000057819245,0.00018924063,0.00009201486,0.00018841459,0.00008964061,0.00009908071,0.00046376785,0.00043382854],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013815917,0.000074670796,0.00011928434,0.000031017895,0.00000388755,0.000038434264,0.00000841623,0.00009385506,0.99787176,0.00007229429,0.0000579715,0.0014901907],"study_design_scores_gemma":[0.000040316856,0.00046384637,0.0008415092,0.0000032370779,0.0000076348715,0.00017145279,0.000009382763,0.00091648096,0.99500304,0.000034720684,0.0025062663,0.0000021719743],"about_ca_topic_score_codex":0.0002907917,"about_ca_topic_score_gemma":0.0002657687,"teacher_disagreement_score":0.0010771126,"about_ca_system_score_codex":0.00019426223,"about_ca_system_score_gemma":0.00021498611,"threshold_uncertainty_score":0.0036033392},"labels":[],"label_agreement":null},{"id":"W2176295651","doi":"10.1089/108497803322287727","title":"Design, Synthesis, and Evaluation of Radiolabeled Integrin α <sub> <i>v</i> </sub> β <sub>3</sub> Receptor Antagonists for Tumor Imaging and Radiotherapy","year":2003,"lang":"en","type":"article","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Vitronectin; Alpha-v beta-3; Integrin; Antagonist; Receptor; Radiation therapy; Medicine; Cancer research; Alpha (finance); Chemistry; Nuclear medicine; Endocrinology; Internal medicine","score_opus":0.05024512640190948,"score_gpt":0.3744839929615905,"score_spread":0.32423886655968104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2176295651","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85751826,0.015713744,0.10984992,0.000402909,0.00016923361,0.0015929374,0.0013135652,0.0006096435,0.012829786],"genre_scores_gemma":[0.8617798,0.011880458,0.10946711,0.0003465359,0.00006116956,0.0009616025,0.002182851,0.00023974215,0.013080818],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99987257,0.000018959005,0.000010116261,0.000027489908,0.000038958224,0.00003182335],"domain_scores_gemma":[0.9998716,0.000013563777,0.00004060464,0.000009297379,0.000032398195,0.00003243483],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021022157,0.0005218464,0.00047121683,0.00013521874,0.00017104557,0.0004579526,0.0006751386,0.00038282215,0.0013838981],"category_scores_gemma":[0.00024650933,0.00023870482,0.00022607691,0.00022821622,0.00015116022,0.00026336533,0.00014004984,0.00049271114,0.0009267477],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011285964,0.00005474133,0.000088314286,0.00008001657,0.00000901366,0.00005400995,0.000019049623,0.00061232003,0.9905657,0.00047102233,0.00016961688,0.007763228],"study_design_scores_gemma":[0.00009564664,0.0012982456,0.00046573082,0.000009155203,0.000046762183,0.00036392768,0.000014454123,0.0017363278,0.98020524,0.00007792304,0.015673615,0.000013058248],"about_ca_topic_score_codex":0.0009477378,"about_ca_topic_score_gemma":0.0016266761,"teacher_disagreement_score":0.0013838981,"about_ca_system_score_codex":0.00067213597,"about_ca_system_score_gemma":0.00046348438,"threshold_uncertainty_score":0.004876673},"labels":[],"label_agreement":null},{"id":"W2178156564","doi":"10.1089/108497802320970271","title":"Fusion of the C <sub>H</sub> 1 Domain of IgG <sub>1</sub> to Epidermal Growth Factor (EGF) Prolongs its Retention in the Blood but Does Not Increase Tumor Uptake","year":2002,"lang":"en","type":"article","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Molecular biology; Fusion protein; Epidermal growth factor; Linker; Chemistry; Western blot; Transfection; Epidermal growth factor receptor; Biology; Receptor; Recombinant DNA; Biochemistry; Gene","score_opus":0.04591234637436718,"score_gpt":0.32581541232119043,"score_spread":0.27990306594682324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2178156564","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98925215,0.001835653,0.005769637,0.00016885664,0.000056426223,0.00003936954,0.00045517005,0.00021595135,0.0022067388],"genre_scores_gemma":[0.98842293,0.00092399894,0.003625555,0.00012456036,0.00002315868,0.0000273962,0.0015830917,0.00004572075,0.0052235005],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99991894,0.000006804519,0.0000035715016,0.000012853169,0.000019041787,0.000038699596],"domain_scores_gemma":[0.9999211,0.000018466855,0.000024129,0.000009472023,0.0000075129356,0.000019342673],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010832553,0.00032947387,0.00028369587,0.00015823497,0.00010109349,0.00023079195,0.00022681164,0.00028996755,0.0017564212],"category_scores_gemma":[0.00009664314,0.00008717918,0.00028391153,0.00013190293,0.0002206358,0.00015038389,0.00013400217,0.0004694148,0.0008088624],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009455049,0.000017366241,0.00014117234,0.000025012108,0.00000550003,0.00003528541,0.000005622974,0.00005230016,0.99840575,0.000070116825,0.000080320446,0.0010671243],"study_design_scores_gemma":[0.000013414502,0.00015838929,0.0021159514,0.0000033507645,0.000013895527,0.00027910367,0.00000769874,0.0003619732,0.9928704,0.000033908942,0.004138733,0.0000032528485],"about_ca_topic_score_codex":0.0013668649,"about_ca_topic_score_gemma":0.0010940148,"teacher_disagreement_score":0.0017564212,"about_ca_system_score_codex":0.0007085122,"about_ca_system_score_gemma":0.00022695378,"threshold_uncertainty_score":0.005875826},"labels":[],"label_agreement":null},{"id":"W2883711541","doi":"10.1089/cbr.2018.2480","title":"Evaluation of N-Succinimidyl S-Acetylthioacetate Ligand for Radiolabeling of Humanized Antibodies with <sup>188</sup> Rhenium","year":2018,"lang":"en","type":"article","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"National Cancer Institute","keywords":"Radioimmunotherapy; Chemistry; Antibody; Conjugate; Conjugated system; Radiochemistry; Reagent; Chelation; Monoclonal antibody; Cancer research; Medicine; Immunology; Organic chemistry; Polymer","score_opus":0.09331406033250034,"score_gpt":0.4293223009010369,"score_spread":0.33600824056853656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2883711541","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897351,0.0014933981,0.007552405,0.00006863818,0.000010321174,0.000042436965,0.000046314388,0.000043228007,0.0010082455],"genre_scores_gemma":[0.9844475,0.0012790416,0.012455064,0.000033813343,0.000005040939,0.000027052865,0.00011167874,0.00002041855,0.0016202738],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998971,0.000034272445,0.0000074332,0.000019734462,0.000026536734,0.000014864324],"domain_scores_gemma":[0.99987626,0.000034884175,0.00003228592,0.000007395112,0.000034773504,0.000014356334],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032731175,0.00024235345,0.0001375515,0.00009563763,0.000077256605,0.00019784454,0.00019905763,0.00024770666,0.00033419798],"category_scores_gemma":[0.00025231708,0.0000927861,0.00012581865,0.00008844905,0.00016113535,0.00015834047,0.000096873075,0.00017435438,0.00014656567],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000073047115,0.000013356055,0.0001345314,0.000023823712,0.00000299,0.00002668381,0.000012724168,0.00012816733,0.9977049,0.000047448426,0.000012659328,0.0018196172],"study_design_scores_gemma":[0.00000457565,0.00032351547,0.000339286,0.0000013536746,0.000005523911,0.00008000921,0.0000048206193,0.0006931706,0.9979517,0.0000037349714,0.0005907344,0.0000017787269],"about_ca_topic_score_codex":0.0006547125,"about_ca_topic_score_gemma":0.001031563,"teacher_disagreement_score":0.0006547125,"about_ca_system_score_codex":0.0002614948,"about_ca_system_score_gemma":0.0001770648,"threshold_uncertainty_score":0.001897335},"labels":[],"label_agreement":null},{"id":"W2888747994","doi":"10.1089/cbr.2018.2481","title":"Radioimmunotherapy as a Novel Approach in HIV, Bacterial, and Fungal Infectious Diseases","year":2018,"lang":"en","type":"review","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Radioimmunotherapy; Cryptococcus neoformans; Antimicrobial; Bacillus anthracis; Medicine; Human immunodeficiency virus (HIV); Pathogen; Immunology; Virology; Microbiology; Biology; Bacteria; Antibody; Monoclonal antibody","score_opus":0.06932892645915954,"score_gpt":0.42211489084561676,"score_spread":0.3527859643864572,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2888747994","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017549636,0.9980363,0.00018960578,0.00018035684,0.00017714172,0.0000057242883,0.0000090312415,0.000008270322,0.0012181392],"genre_scores_gemma":[0.0011778595,0.99737203,0.00026314062,0.00018579043,0.0001619254,0.000009128561,0.000020230262,0.0000018981054,0.00080792705],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998109,0.000032862015,0.000023471095,0.00003456196,0.00007732949,0.00002093871],"domain_scores_gemma":[0.9997867,0.00010611962,0.000030288888,0.000007530977,0.00004984724,0.000019595534],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051484816,0.00076578505,0.0009970716,0.0023886554,0.0003289635,0.00094927906,0.0007222635,0.0011299901,0.0038646632],"category_scores_gemma":[0.00047849177,0.00027552934,0.0004936979,0.0016659279,0.0005171692,0.0012530533,0.0006297058,0.0020463567,0.0016732847],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057920937,0.00013535147,0.00020257597,0.015428809,0.000075364835,0.00029520737,0.000094525705,0.00040550332,0.0050181877,0.0071086828,0.022064492,0.9491134],"study_design_scores_gemma":[0.000010367926,0.00009672134,0.00045327237,0.0015184905,0.000058672354,0.0015588122,0.00003575023,0.00008720522,0.0010436083,0.0016260956,0.993497,0.000013923086],"about_ca_topic_score_codex":0.0006540792,"about_ca_topic_score_gemma":0.0012761087,"teacher_disagreement_score":0.0038646632,"about_ca_system_score_codex":0.00057516433,"about_ca_system_score_gemma":0.0007384504,"threshold_uncertainty_score":0.012928605},"labels":[],"label_agreement":null},{"id":"W2906781095","doi":"10.1089/cbr.2018.2628","title":"An IL-15 Superagonist, ALT-803, Enhances Antibody-Dependent Cell-Mediated Cytotoxicity Elicited by the Monoclonal Antibody NEO-201 Against Human Carcinoma Cells","year":2019,"lang":"en","type":"article","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Precision BioLogic (Canada)","funders":"","keywords":"Monoclonal antibody; Cytotoxicity; Antibody; Antibody-dependent cell-mediated cytotoxicity; Cancer research; Immunology; Biology; Chemistry; In vitro; Biochemistry","score_opus":0.013762383110684832,"score_gpt":0.3207886466733311,"score_spread":0.3070262635626463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906781095","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967764,0.0010982597,0.00074347906,0.000044737742,0.000019270074,0.000024649338,0.00011805512,0.00004134094,0.0011338615],"genre_scores_gemma":[0.9980248,0.00045277187,0.0007165207,0.000035864865,0.000011294803,0.000017914666,0.0001635059,0.000004575632,0.0005727933],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99993384,0.000012504445,0.000007544854,0.0000085514785,0.00001678932,0.000020754236],"domain_scores_gemma":[0.99994206,0.00001671104,0.00001528852,0.0000070528113,0.000006554274,0.000012368559],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000115480136,0.0003183417,0.00018668463,0.00012743103,0.00006348398,0.00014354689,0.000087960034,0.00012954754,0.0011951671],"category_scores_gemma":[0.00008984317,0.00005939454,0.00018086367,0.00010741039,0.00013161157,0.0001141374,0.000111696,0.00030661264,0.00026362712],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004393509,0.000099539386,0.0003824965,0.00005550487,0.0000054377892,0.000057100617,0.000014431433,0.00011176336,0.99625254,0.00003973971,0.000048801263,0.0024932844],"study_design_scores_gemma":[0.00004772313,0.001167108,0.0025724792,0.000004022645,0.000020509828,0.0002460908,0.000009580848,0.0004163881,0.9945597,0.000018488397,0.0009357918,0.0000020755797],"about_ca_topic_score_codex":0.00019122551,"about_ca_topic_score_gemma":0.0003280853,"teacher_disagreement_score":0.0011951671,"about_ca_system_score_codex":0.00019533878,"about_ca_system_score_gemma":0.0001616976,"threshold_uncertainty_score":0.00399822},"labels":[],"label_agreement":null},{"id":"W2909850450","doi":"10.1089/cbr.2018.2566","title":"Lentivirus-Based Virus-Like Particles Mediate Delivery of Caspase 8 into Breast Cancer Cells and Inhibit Tumor Growth","year":2019,"lang":"en","type":"article","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"National Natural Science Foundation of China","keywords":"Apoptosis; Carcinogenesis; Cancer research; Cancer cell; Cancer; Programmed cell death; Breast cancer; Vesicular stomatitis virus; Cell growth; Biology; Caspase; Virus; Chemistry; Immunology; Biochemistry","score_opus":0.012012221459266203,"score_gpt":0.2864272114355402,"score_spread":0.27441498997627395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2909850450","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97528344,0.0039651776,0.015825903,0.00030952523,0.00014836928,0.00015593397,0.00042732977,0.00030134092,0.0035829702],"genre_scores_gemma":[0.98492223,0.0012520314,0.009451334,0.00009258206,0.000024447538,0.00009482223,0.00045586328,0.000027951188,0.0036788003],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998647,0.00002026356,0.0000122701385,0.000022547372,0.00005236435,0.00002781522],"domain_scores_gemma":[0.9999317,0.000018581986,0.000020677993,0.000008040266,0.000010752583,0.0000102992335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020365286,0.00030222908,0.00017213146,0.00019730181,0.000112820286,0.00028752792,0.00026510542,0.00045032435,0.0008893382],"category_scores_gemma":[0.00016799294,0.00009583373,0.00024252426,0.000091397815,0.00024369919,0.00024593674,0.00013513186,0.00074199255,0.00025451794],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008717713,0.000064939806,0.00014676325,0.00005147185,0.000008480783,0.000046302514,0.000018825545,0.00013557533,0.99590576,0.00044216038,0.00011761042,0.0029750783],"study_design_scores_gemma":[0.00004045631,0.0003103185,0.00041078147,0.0000063512857,0.000014615475,0.0001233012,0.000008522432,0.0010862548,0.995,0.00007096052,0.0029261592,0.0000023705177],"about_ca_topic_score_codex":0.0003442363,"about_ca_topic_score_gemma":0.00030947695,"teacher_disagreement_score":0.0008893382,"about_ca_system_score_codex":0.0004523092,"about_ca_system_score_gemma":0.00027028506,"threshold_uncertainty_score":0.0032817721},"labels":[],"label_agreement":null},{"id":"W2913881018","doi":"10.1089/cbr.2018.2732","title":"<i>In Vitro</i> Characterization of a Potent p53-MDM2 Inhibitor, RG7112 in Neuroblastoma Cancer Cell Lines","year":2019,"lang":"en","type":"article","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Mdm2; Cancer research; Neuroblastoma; Cell culture; Ubiquitin ligase; Biology; Cell growth; Cell cycle; In vitro; Cancer cell; Cancer; Cell cycle checkpoint; Ubiquitin; Chemistry; Biochemistry; Genetics","score_opus":0.012083945139838782,"score_gpt":0.3017509563785083,"score_spread":0.2896670112386695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913881018","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9556705,0.01763653,0.010738963,0.00040007007,0.00014263965,0.00031054683,0.0054151556,0.00032952504,0.009356018],"genre_scores_gemma":[0.9521965,0.011373117,0.014560179,0.00018615561,0.000060278217,0.00040609628,0.014323568,0.00006766625,0.0068265],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998267,0.00004254242,0.000025123736,0.000024234345,0.000051459003,0.000029871731],"domain_scores_gemma":[0.99991333,0.000020214939,0.000015896892,0.000011242277,0.000026210919,0.000013165256],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002598783,0.0005544186,0.00048094388,0.00027270187,0.00017682825,0.00020216797,0.0003705593,0.00028423543,0.0012096236],"category_scores_gemma":[0.00013601985,0.00013953837,0.00036058834,0.0003494501,0.00011405407,0.00013991664,0.00010210056,0.00038822985,0.00076352584],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003358683,0.00014182471,0.00024931686,0.00018955507,0.000019957743,0.00009824455,0.000020961621,0.0005634196,0.9942966,0.00007505357,0.0004799905,0.003529206],"study_design_scores_gemma":[0.000042491374,0.0009765447,0.0013693556,0.000008944274,0.00003749636,0.0002184097,0.000010258728,0.0007506173,0.9933289,0.0000116786,0.003239006,0.0000062370746],"about_ca_topic_score_codex":0.0022612927,"about_ca_topic_score_gemma":0.0027916434,"teacher_disagreement_score":0.0022612927,"about_ca_system_score_codex":0.0003263552,"about_ca_system_score_gemma":0.00026431622,"threshold_uncertainty_score":0.004496217},"labels":[],"label_agreement":null},{"id":"W2999126010","doi":"10.1089/cbr.2019.3141","title":"The Monoclonal Antibody NEO-201 Enhances Natural Killer Cell Cytotoxicity Against Tumor Cells Through Blockade of the Inhibitory CEACAM5/CEACAM1 Immune Checkpoint Pathway","year":2020,"lang":"en","type":"article","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Precision BioLogic (Canada)","funders":"","keywords":"Cytotoxicity; Lymphokine-activated killer cell; Cancer research; NK-92; Biology; Antibody; Interleukin 21; Interleukin 12; Monoclonal antibody; Immune system; Cancer cell; Innate immune system; Natural killer cell; Carcinoembryonic antigen; Cell culture; Cytotoxic T cell; In vitro; Immunology; Cancer; T cell","score_opus":0.027605382548131486,"score_gpt":0.3385589504733103,"score_spread":0.3109535679251788,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2999126010","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99542266,0.0012519818,0.0010296385,0.00007070966,0.000031074873,0.00003381974,0.00008122991,0.000062039566,0.0020169574],"genre_scores_gemma":[0.9966047,0.00053404534,0.0009934043,0.000047045294,0.000010240736,0.000025638601,0.00022718192,0.000006205441,0.0015515297],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999021,0.000013526859,0.0000096325975,0.000013285343,0.000028367538,0.000033071457],"domain_scores_gemma":[0.999949,0.000012405809,0.000010893639,0.0000054315356,0.00000838367,0.000013984974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000088605564,0.00032025736,0.00023026047,0.00015533227,0.00007325044,0.0001729318,0.00017990549,0.00019836967,0.0017203826],"category_scores_gemma":[0.000078140234,0.00007965668,0.00019542988,0.00008195394,0.0001362864,0.00014223154,0.00014275913,0.00051501207,0.00032859083],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012254751,0.00010153579,0.00015261164,0.000041454023,0.0000049652285,0.000025332847,0.000005058482,0.00004757811,0.99783057,0.00004915722,0.000041178686,0.0015780082],"study_design_scores_gemma":[0.00003683314,0.0010110699,0.0020115478,0.0000048412253,0.00001959984,0.00019821867,0.0000073425977,0.0004668764,0.99497116,0.000015243668,0.0012551417,0.0000020724378],"about_ca_topic_score_codex":0.00033099734,"about_ca_topic_score_gemma":0.0005641034,"teacher_disagreement_score":0.0017203826,"about_ca_system_score_codex":0.00025321022,"about_ca_system_score_gemma":0.0002253813,"threshold_uncertainty_score":0.005755186},"labels":[],"label_agreement":null},{"id":"W312288375","doi":"10.1089/cbr.2008.0595","title":"Y-90 Microsphere Therapy: Prevention of Adverse Events","year":2009,"lang":"en","type":"article","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Patient Safety and Medication Errors","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Adverse effect; Medicine; Microsphere; Leak; Emergency medicine; Surgery; Nuclear medicine; Anesthesia; Internal medicine; Environmental science","score_opus":0.11205657925206093,"score_gpt":0.5094028433593557,"score_spread":0.3973462641072948,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W312288375","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9854732,0.005515399,0.005299471,0.00017890176,0.000026345615,0.0003241986,0.0011438868,0.00009829378,0.0019402727],"genre_scores_gemma":[0.9940631,0.0013547506,0.0032142496,0.00010537696,0.00004006186,0.000098463344,0.0007587213,0.000014295875,0.00035104656],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99745363,0.0007502807,0.00046831652,0.00027674373,0.0009372791,0.00011360259],"domain_scores_gemma":[0.989096,0.0023280547,0.007174953,0.0002491253,0.0009511788,0.00020080438],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036676324,0.00025269,0.00034532088,0.00096002076,0.00019312292,0.0004398335,0.00022812266,0.0002375433,0.0008334304],"category_scores_gemma":[0.006185892,0.00008778139,0.00037794313,0.000802602,0.00021626282,0.00022178296,0.00032737793,0.0002849349,0.00020227808],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00094746996,0.0000697887,0.9190892,0.00032163385,0.00015280253,0.00032354138,0.00013229619,0.0005614106,0.0034814375,0.00005283177,0.0006307539,0.07423689],"study_design_scores_gemma":[0.00002634403,0.0009533281,0.9910744,0.00005997237,0.0000860937,0.0012781203,0.00007259648,0.00082522753,0.0035757322,0.000023564648,0.0020169264,0.0000077921095],"about_ca_topic_score_codex":0.0012347808,"about_ca_topic_score_gemma":0.0014530503,"teacher_disagreement_score":0.0036676324,"about_ca_system_score_codex":0.0005209446,"about_ca_system_score_gemma":0.0009097098,"threshold_uncertainty_score":0.019396544},"labels":[],"label_agreement":null},{"id":"W4223897956","doi":"10.1089/cbr.2021.0276","title":"Potential Theranostic Boron Neutron Capture Therapy Agents as Multimodal Radiopharmaceuticals","year":2022,"lang":"en","type":"review","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Boron Compounds in Chemistry","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Neutron capture; Medicine; Prostate cancer; Boron; Cancer research; Cancer; Medical physics; Chemistry; Internal medicine","score_opus":0.10283845211229665,"score_gpt":0.4526838067473997,"score_spread":0.3498453546351031,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4223897956","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00048308712,0.9959223,0.0002982558,0.00018632873,0.0001393277,0.000009333646,0.000024700808,0.000010612778,0.002925915],"genre_scores_gemma":[0.0026107586,0.9948378,0.0004386954,0.00021183568,0.000088807734,0.000017586994,0.000044431297,0.0000021920007,0.0017478754],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99991107,0.000015144963,0.000008132687,0.000017189699,0.000032697277,0.000015850457],"domain_scores_gemma":[0.99993956,0.000024055462,0.000010888633,0.000002050457,0.00001619832,0.000007301337],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002936314,0.0006519647,0.00076293707,0.0017149118,0.00018294343,0.0005843215,0.00047058056,0.0007990024,0.0035266008],"category_scores_gemma":[0.00023600481,0.00022176944,0.00040446702,0.0011603516,0.0002507611,0.00075882836,0.00042445507,0.0011353353,0.001567117],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010963614,0.00016665176,0.00015088677,0.018540064,0.000077375604,0.00035428477,0.00007340797,0.000948614,0.014125004,0.011738485,0.022164172,0.93155146],"study_design_scores_gemma":[0.000021346936,0.00012012893,0.00040188007,0.0015650279,0.000055951088,0.0010077667,0.000028763383,0.00017350692,0.0030161052,0.0018470077,0.991747,0.000015593701],"about_ca_topic_score_codex":0.0005933141,"about_ca_topic_score_gemma":0.0013318013,"teacher_disagreement_score":0.0035266008,"about_ca_system_score_codex":0.0005045071,"about_ca_system_score_gemma":0.00047346286,"threshold_uncertainty_score":0.011797667},"labels":[],"label_agreement":null},{"id":"W4297216557","doi":"10.1089/cbr.2022.0057","title":"Strategies for Preclinical Studies Evaluating the Biological Effects of an Accelerator-Based Boron Neutron Capture Therapy System","year":2022,"lang":"en","type":"review","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Boron Compounds in Chemistry","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Particle Physics","funders":"","keywords":"Neutron capture; Medicine; Medical physics; Head and neck; Clinical trial; Nuclear medicine; Neutron source; Cancer; Neutron; Surgery; Pathology; Internal medicine; Nuclear physics; Physics","score_opus":0.4739507947529298,"score_gpt":0.5819290519360126,"score_spread":0.10797825718308285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4297216557","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00075648644,0.98971856,0.0025614311,0.00022129572,0.00025764073,0.00012732424,0.00008965884,0.00004371694,0.0062239156],"genre_scores_gemma":[0.0028293636,0.9907788,0.0035602984,0.00027591374,0.00011825204,0.00016204485,0.00020655626,0.0000084276035,0.002060454],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997004,0.00004621736,0.00004165352,0.000047622736,0.00013926132,0.00002472825],"domain_scores_gemma":[0.9997764,0.000075768214,0.00003805827,0.000012755293,0.00008040065,0.000016560596],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009978551,0.0013980643,0.0015478374,0.003464342,0.00032276774,0.00094115007,0.0008680323,0.0010839021,0.0035587212],"category_scores_gemma":[0.00053976564,0.00053778896,0.00085533765,0.0015382385,0.00043596726,0.0014907704,0.00068376004,0.0018845755,0.0026955071],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013741935,0.0003681691,0.00020808636,0.03508477,0.00015195436,0.00033616557,0.00011153538,0.0010952511,0.04860255,0.012325507,0.014688527,0.88689005],"study_design_scores_gemma":[0.000058168116,0.0004997729,0.000479382,0.0021174909,0.00023337337,0.0009871563,0.000039723538,0.0001930216,0.010979513,0.0013382181,0.9830341,0.00004014214],"about_ca_topic_score_codex":0.0008011017,"about_ca_topic_score_gemma":0.0012675765,"teacher_disagreement_score":0.0035587212,"about_ca_system_score_codex":0.00075765274,"about_ca_system_score_gemma":0.0012918279,"threshold_uncertainty_score":0.011905134},"labels":[],"label_agreement":null},{"id":"W4408160466","doi":"10.1089/cbr.2024.0202","title":"Diagnostic Value of <sup>99m</sup> Tc-Ubiquicidin Scintigraphy in Differentiating Bacterial from Nonbacterial Pneumonia","year":2025,"lang":"en","type":"article","venue":"Cancer Biotherapy and Radiopharmaceuticals","topic":"Pneumonia and Respiratory Infections","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Pneumonia; Medicine; Scintigraphy; Bacterial pneumonia; Value (mathematics); Nuclear medicine; Radiology; Internal medicine; Computer science","score_opus":0.01457050027567186,"score_gpt":0.3390874867133751,"score_spread":0.3245169864377032,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408160466","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985707,0.0007703098,0.00035486495,0.00002697237,0.000004106597,0.000011825223,0.000016804528,0.0000070929314,0.00023730991],"genre_scores_gemma":[0.99930966,0.00013411112,0.00045554733,0.00001904253,0.000008174842,0.0000057887432,0.000038465794,0.0000011860689,0.000027980192],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996138,0.00015454879,0.000051435287,0.00006807618,0.0000561908,0.00005591795],"domain_scores_gemma":[0.99893206,0.0004895243,0.00016004147,0.00005080593,0.00011837848,0.00024914028],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010358114,0.00044641068,0.00045327167,0.0005904858,0.00024047542,0.0005179469,0.00023947466,0.0006417157,0.0009693183],"category_scores_gemma":[0.0024639727,0.00020918544,0.00016616739,0.00022404587,0.0007191364,0.00040976447,0.000432175,0.00029718762,0.00034374685],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005106904,0.00017200898,0.9496686,0.000075407115,0.000053009055,0.0009603196,0.0001276827,0.00027373922,0.026360253,0.00002483551,0.00009295184,0.017084235],"study_design_scores_gemma":[0.00031713195,0.006674881,0.96427023,0.000047673228,0.0001300321,0.010599534,0.000548838,0.005232511,0.011642593,0.00012539745,0.00038279805,0.000028320816],"about_ca_topic_score_codex":0.00032027965,"about_ca_topic_score_gemma":0.00038471248,"teacher_disagreement_score":0.0010358114,"about_ca_system_score_codex":0.00018333914,"about_ca_system_score_gemma":0.00020311454,"threshold_uncertainty_score":0.005477965},"labels":[],"label_agreement":null}]}